Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity

Circulation

Volumn 133, Issue 2, 2016, Pages 187-225

  Mozaffarian, Dariush ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

cardiovascular diseases; delivery of health care; diabetes mellitus; diet; nutrition; obesity; policy; prevention and control; review

Indexed keywords

ALCOHOL; CALCIUM; CARBOHYDRATE; FAT; FATTY ACID; FRUCTOSE; LIPID; MAGNESIUM; MONOUNSATURATED FATTY ACID; PHENOL DERIVATIVE; POLYUNSATURATED FATTY ACID; POTASSIUM; PROBIOTIC AGENT; SATURATED FATTY ACID; SODIUM; SODIUM CHLORIDE; STARCH; SWEETENING AGENT; TRANS FATTY ACID; VEGETABLE OIL; VITAMIN; VITAMIN D; YOGHURT;

ABDOMINAL OBESITY; BEHAVIOR CHANGE; BUTTER; CARDIOVASCULAR DISEASE; CHEESE; COFFEE; DIABETES MELLITUS; DIET; DIET SUPPLEMENTATION; DNA MODIFICATION; EGG; ENERGY BALANCE; FERMENTATION; FISH; FOOD PROCESSING; FRUIT; FRUIT JUICE; FUNCTIONAL FOOD; HEALTH CARE SYSTEM; HEREDITY; HUMAN; LEGUME; LIPID BLOOD LEVEL; MILK; NUT; NUTRIENT; NUTRITION; OBESITY; PHYSICAL ACTIVITY; POLICY; PRIORITY JOURNAL; RED MEAT; REFINED GRAIN; REVIEW; SOCIAL STATUS; TEA; VEGETABLE; WEIGHT GAIN; WHOLE GRAIN; ADVERSE EFFECTS; ALTERNATIVE MEDICINE; CARDIOVASCULAR DISEASES; DIET THERAPY; DIETARY REFERENCE INTAKE; DIETARY SUPPLEMENT; ENERGY METABOLISM; FEEDING BEHAVIOR; FOOD; FOOD PREFERENCE; FORECASTING; GENETIC PREDISPOSITION; GENETICALLY MODIFIED FOOD; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROMOTION; NUTRITION POLICY; NUTRITIONAL SCIENCE; NUTRITIONAL VALUE; PERSONALIZED MEDICINE; RISK FACTOR; STANDARDS; TRENDS; UNITED STATES;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DIET; DIET FADS; DIETARY SUPPLEMENTS; ENERGY METABOLISM; FEEDING BEHAVIOR; FOOD; FOOD PREFERENCES; FOOD, GENETICALLY MODIFIED; FORECASTING; GENETIC PREDISPOSITION TO DISEASE; HEALTH POLICY; HEALTH PRIORITIES; HEALTH PROMOTION; HUMANS; NUTRITION POLICY; NUTRITIONAL SCIENCES; NUTRITIVE VALUE; OBESITY; PRECISION MEDICINE; RECOMMENDED DIETARY ALLOWANCES; RISK FACTORS; UNITED STATES; WEIGHT GAIN;

EID: 84956599732     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.018585     Document Type: Review

References (406)

1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng AT, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD 3rd, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S, Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L, Marks R, Martin R, McGale P, McGrath J, Mehta S, Mensah GA, Merriman TR, Micha R, Michaud C, Mishra V, Mohd Hanafiah K, Mokdad AA, Morawska L, Mozaffarian D, Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R, Olives C, Omer SB, Orchard J, Osborne R, Ostro B, Page A, Pandey KD, Parry CD, Passmore E, Patra J, Pearce N, Pelizzari PM, Petzold M, Phillips MR, Pope D, Pope CA 3rd, Powles J, Rao M, Razavi H, Rehfuess EA, Rehm JT, Ritz B, Rivara FP, Roberts T, Robinson C, Rodriguez-Portales JA, Romieu I, Room R, Rosenfeld LC, Roy A, Rushton L, Salomon JA, Sampson U, Sanchez-Riera L, Sanman E, Sapkota A, Seedat S, Shi P, Shield K, Shivakoti R, Singh GM, Sleet DA, Smith E, Smith KR, Stapelberg NJ, Steenland K, Stöckl H, Stovner LJ, Straif K, Straney L, Thurston GD, Tran JH, Van Dingenen R, van Donkelaar A, Veerman JL, Vijayakumar L, Weintraub R, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams W, Wilson N, Woolf AD, Yip P, Zielinski JM, Lopez AD, Murray CJ, Ezzati M, AlMazroa MA, Memish ZA. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-2260. doi: 10.1016/S0140-6736(12)61766-8.
2. US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310:591-608
3. Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, Feigl AB, Gaziano T, Mowafi M, Pandya A, Prettner K, Rosenberg L, Seligman B, Stein AZ, Weinstein C. The Global Economic Burden of Noncommunicable Diseases. Geneva, Switzerland: World Economic Forum; 2011.
4. Imamura F, Micha R, Khatibzadeh S, Fahimi S, Shi P, Powles J, Mozaffarian D. Dietary quality among men and women in 187 countries in 1990 and 2010: a systematic assessment. Lancet Glob Health. 2015;3:e132-e142
5. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343:16-22. doi: 10.1056/NEJM200007063430103.
6. Blumberg J, Heaney RP, Huncharek M, Scholl T, Stampfer M, Vieth R, Weaver CM, Zeisel SH. Evidence-based criteria in the nutritional context. Nutr Rev. 2010;68:478-484. doi: 10.1111/j.1753-4887.2010.00307.x.
7. Satija A, Yu E, Willett WC, Hu FB. UnderstanDing nutritional epidemiology and its role in policy. Adv Nutr. 2015;6:5-18. doi: 10.3945/an.114.007492.
8. Jacobs DR Jr, Tapsell LC. Food, not nutrients, is the fundamental unit in nutrition. Nutr Rev. 2007;65:439-450.
9. Mozaffarian D, Ludwig DS. Dietary guidelines in the 21st century-a time for food. JAMA. 2010;304:681-682. doi: 10.1001/jama.2010.1116.
10. Afshin A, Micha R, Khatibzadeh S, Schmidt LA, Mozaffarian D. Dietary policies to reduce non-communicable diseases. In: Brown GW, Yamey G, Wamala S, eds. The Handbook of Global Health Policy, 1st ed. West Sussex, UK: John Wiley & Sons, Ltd; 2014.
11. Mozaffarian D, Afshin A, Benowitz NL, Bittner V, Daniels SR, Franch HA, Jacobs DR Jr, Kraus WE, Kris-Etherton PM, Krummel DA, Popkin BM, Whitsel LP, Zakai NA; American Heart Association Council on Epidemiology and Prevention, Council on Nutrition, Physical Activity and Metabolism, Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on the Kidney in Cardiovasc. Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation. 2012;126:1514-1563. doi: 10.1161/CIR.0b013e318260a20b.
12. Lind J. A Treatise of the Scurvy. London: A. Millar; 1753.
13. National Nutrition Conference for Defense. National Nutrition Conference for Defense. JAMA. 1941;116:2598-2599.
14. Davis C, Saltos E. Dietary recommendations and how they have changed over time. America's Eating Habits: Changes and Consequences. Washington, DC: US Department of Agriculture, Economic Research Service; 1999. Agriculture Information Bulletin No. 750.
15. American Medical Association. National nutrition. JAMA. 1941;116:2854-2855.
16. Harper AE. Evolution of recommended dietary allowances-new directions? Annu Rev Nutr. 1987;7:509-537. doi: 10.1146/annurev.nu.07.070187.002453.
17. Jacobs DR, Tapsell LC. Food synergy: the key to a healthy diet. Proc Nutr Soc. 2013;72:200-206. doi: 10.1017/S0029665112003011.
18. Fardet A. A shift toward a new holistic paradigm will help to preserve and better process grain products' food structure for improving their health effects. Food Funct. 2015;6:363-382. doi: 10.1039/c4fo00477a.
19. Mozaffarian D, Appel LJ, Van Horn L. Components of a cardioprotective diet: new insights. Circulation. 2011;123:2870-2891. doi: 10.1161/CIRCULATIONAHA.110.968735.
20. Mozaffarian D. Nutrition and cardiovascular disease and metabolic diseases. In: Mann DL, Zipes DP, Libby P, Bonow RO, eds. Braunwald's Heart Disease; A Textbook of Cardiovascular Medicine, 10th ed. Philadelphia, PA: Elsevier/Saunders; 2014;1001-1014.
21. Dietary Guidelines Advisory Committee. Scientific Report of the 2015 Dietary Guidelines Advisory Committee. 2015. http://www.health.gov/dietaryguidelines/2015-scientific-report/. Accessed March 25, 2015.
22. Mozaffarian D, Ludwig DS.Dietary cholesterol and blood cholesterol concentrations-reply. JAMA. 2015;314:2084-2085.
23. Perrin AE, Simon C, Hedelin G, Arveiler D, Schaffer P, Schlienger JL. Ten-year trends of dietary intake in a middle-aged French population: relationship with educational level. Eur J Clin Nutr. 2002;56:393-401. doi: 10.1038/sj.ejcn.1601322.
24. Harvard Heart Letter. Latest thinking on a "cardioprotective" diet. 2011. www.health.harvard.edu. Accessed December 12, 2013.
25. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER 3rd, Conlin PR, Erlinger TP, Rosner BA, Laranjo NM, Charleston J, McCarron P, Bishop LM; OmniHeart Collaborative Research Group. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA. 2005;294:2455-2464. doi: 10.1001/jama.294.19.2455.
26. Gadgil MD, Appel LJ, Yeung E, Anderson CA, Sacks FM, Miller ER 3rd. The effects of carbohydrate, unsaturated fat, and protein intake on measures of insulin sensitivity: results from the OmniHeart trial. Diabetes Care. 2013;36:1132-1137. doi: 10.2337/dc12-0869.
27. Haring B, von Ballmoos MC, Appel LJ, Sacks FM. Healthy dietary interventions and lipoprotein (a) plasma levels: results from the Omni Heart Trial. PLoS One. 2014;9:e114859. doi: 10.1371/journal.pone.0114859.
28. Djoussé L, Akinkuolie AO, Wu JH, Ding EL, Gaziano JM. Fish consumption, omega-3 fatty acids and risk of heart failure: a meta-analysis. Clin Nutr. 2012;31:846-853. doi: 10.1016/j.clnu.2012.05.010.
29. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364:2392-2404. doi: 10.1056/NEJMoa1014296.
30. Smith JD, Hou T, Ludwig DS, Rimm EB, Willett W, Hu FB, Mozaffarian D. Changes in intake of protein foods, carbohydrate amount and quality, and long-term weight change: results from 3 prospective cohorts. Am J Clin Nutr. 2015;101:1216-1224. doi: 10.3945/ajcn.114.100867.
31. Lou-Bonafonte JM, Gabás-Rivera C, Navarro MA, Osada J. PON1 and Mediterranean Diet. Nutrients. 2015;7:4068-4092. doi: 10.3390/nu7064068.
32. Anand SS, Hawkes C, de Souza RJ, Mente A, Dehghan M, Nugent R, Zulyniak MA, Weis T, Bernstein AM, Krauss RM, Kromhout D, Jenkins DJ, Malik V, Martinez-Gonzalez MA, Mozaffarian D, Yusuf S, Willett WC, Popkin BM. Food consumption and its impact on cardiovascular disease: importance of solutions focused on the globalized food system: a report from the Workshop Convened by the World Heart Federation. J Am Coll Cardiol. 2015;66:1590-1614. doi: 10.1016/j.jacc.2015.07.050.
33. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99:779-785.
34. Estruch R, Martínez-González MA, Corella D, Salas-Salvadó J, Ruiz-Gutiérrez V, Covas MI, Fiol M, Gómez-Gracia E, López-Sabater MC, Vinyoles E, Arós F, Conde M, Lahoz C, Lapetra J, Sáez G, Ros E; PREDIMED Study Investigators. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006;145:1-11.
35. Estruch R, Ros E, Salas-Salvado J, Covas MI, Pharm D, Corella D, Aros F, Gomez-Gracia E, Ruiz-Gutierrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pinto X, Basora J, Munoz MA, Sorli JV, Martinez JA, Martinez-Gonzalez MA. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279-1290.
36. Salas-Salvadó J, Bulló M, Estruch R, Ros E, Covas MI, Ibarrola-Jurado N, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Romaguera D, Lapetra J, Lamuela-Raventós RM, Serra-Majem L, Pintó X, Basora J, Muñoz MA, Sorlí JV, Martínez-González MA. Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial. Ann Intern Med. 2014;160:1-10. doi: 10.7326/M13-1725.
37. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Schatz IJ, Snetselaar LG, Stevens VJ, Tinker LF, Trevisan M, Vitolins MZ, Anderson GL, Assaf AR, Bassford T, Beresford SA, Black HR, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Granek I, Greenland P, Hays J, Heber D, Heiss G, Hendrix SL, Hubbell FA, Johnson KC, Kotchen JM. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295:655-666. doi: 10.1001/jama.295.6.655.
38. Tinker LF, Bonds DE, Margolis KL, Manson JE, Howard BV, Larson J, Perri MG, Beresford SA, Robinson JG, Rodríguez B, Safford MM, Wenger NK, Stevens VJ, Parker LM; Women's Health Initiative. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Arch Intern Med. 2008;168:1500-1511. doi: 10.1001/archinte.168.14.1500.
39. Micha R, Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids. 2010;45:893-905. doi: 10.1007/s11745-010-3393-4.
40. Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, Franco OH, Butterworth AS, Forouhi NG, Thompson SG, Khaw KT, Mozaffarian D, Danesh J, Di Angelantonio E. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160:398-406. doi: 10.7326/M13-1788.
41. Roncaglioni MC, Tombesi M, Avanzini F, Barlera S, Caimi V, Longoni P, Marzona I, Milani V, Silletta MG, Tognoni G, Marchioli R. n-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med. 2013;368:1800-1808
42. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation. 2015;131:e29-e322. doi: 10.1161/CIR.0000000000000152.
43. Albrecht SS, Gordon-Larsen P, Stern D, Popkin BM. Is waist circumference per body mass index rising differentially across the United States, England, China and Mexico? Eur J Clin Nutr. 2015
44. de Onis M, Blössner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 2010;92:1257-1264. doi: 10.3945/ajcn.2010.29786.
45. Estrada E, Eneli I, Hampl S, Mietus-Snyder M, Mirza N, Rhodes E, Sweeney B, Tinajero-Deck L, Woolford SJ, Pont SJ; Children's Hospital Association. Children's Hospital Association consensus statements for comorbidities of childhood obesity. Child Obes. 2014;10:304-317. doi: 10.1089/chi.2013.0120.
46. Brand-Miller J, McMillan-Price J, Steinbeck K, Caterson I. Dietary glycemic index: health implications. J Am Coll Nutr. 2009;28(suppl):446S-449S.
47. Volk BM, Kunces LJ, Freidenreich DJ, Kupchak BR, Saenz C, Artistizabal JC, Fernandez ML, Bruno RS, Maresh CM, Kraemer WJ, Phinney SD, Volek JS. Effects of step-wise increases in dietary carbohydrate on circulating saturated fatty acids and palmitoleic acid in adults with metabolic syndrome. PLoS One. 2014;9:e113605. doi: 10.1371/journal. pone.0113605.
48. Ludwig DS, Friedman MI. Increasing adiposity: consequence or cause of overeating? JAMA. 2014;311:2167-2168. doi: 10.1001/jama.2014.4133.
49. Browning JD, Baker JA, Rogers T, Davis J, Satapati S, Burgess SC. Shortterm weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr. 2011;93:1048-1052. doi: 10.3945/ajcn.110.007674.
50. Lennerz BS, Alsop DC, Holsen LM, Stern E, Rojas R, Ebbeling CB, Goldstein JM, Ludwig DS. Effects of dietary glycemic index on brain regions related to reward and craving in men. Am J Clin Nutr. 2013;98:641-647. doi: 10.3945/ajcn.113.064113.
51. Ebbeling CB, Swain JF, Feldman HA, Wong WW, Hachey DL, Garcia-Lago E, Ludwig DS. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA. 2012;307:2627-2634. doi: 10.1001/jama.2012.6607.
52. Wang H, Troy LM, Rogers GT, Fox CS, McKeown NM, Meigs JB, Jacques PF. Longitudinal association between dairy consumption and changes of body weight and waist circumference: the Framingham Heart Study. Int J Obes (Lond). 2014;38:299-305. doi: 10.1038/ijo.2013.78.
53. Poutahidis T, Kleinewietfeld M, Smillie C, Levkovich T, Perrotta A, Bhela S, Varian BJ, Ibrahim YM, Lakritz JR, Kearney SM, Chatzigiagkos A, Hafler DA, Alm EJ, Erdman SE. Microbial reprogramming inhibits Western diet-associated obesity. PLoS One. 2013;8:e68596. doi: 10.1371/journal.pone.0068596.
54. Park DY, Ahn YT, Park SH, Huh CS, Yoo SR, Yu R, Sung MK, McGregor RA, Choi MS. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One. 2013;8:e59470. doi: 10.1371/journal.pone.0059470.
55. Power SE, O'Toole PW, Stanton C, Ross RP, Fitzgerald GF. Intestinal microbiota, diet and health. Br J Nutr. 2014;111:387-402. doi: 10.1017/S0007114513002560.
56. Bertoia ML, Mukamal KJ, Cahill LE, Hou T, Ludwig DS, Mozaffarian D, Willett WC, Hu FB, Rimm EB. Changes in intake of fruits and vegetables and weight change in United States men and women followed for up to 24 years: analysis from three prospective cohort studies. PLoS Med. 2015;12:e1001878. doi: 10.1371/journal.pmed.1001878.
57. Food and Nutrition Service, US Department of Agriculture. Nutrition standards in the national school lunch and school breakfast programs. 2012. https://www.federalregister.gov/articles/2012/01/26/2012-1010/nutrition-standards-in-the-national-school-lunch-and-school-breakfastprograms. Accessed May 26, 2015.
58. Sluijs I, Forouhi NG, Beulens JW, van der Schouw YT, Agnoli C, Arriola L, Balkau B, Barricarte A, Boeing H, Bueno-de-Mesquita HB, Clavel-Chapelon F, Crowe FL, de Lauzon-Guillain B, Drogan D, Franks PW, Gavrila D, Gonzalez C, Halkjaer J, Kaaks R, Moskal A, Nilsson P, Overvad K, Palli D, Panico S, Quirós JR, Ricceri F, Rinaldi S, Rolandsson O, Sacerdote C, Sánchez MJ, Slimani N, Spijkerman AM, Teucher B, Tjonneland A, Tormo MJ, Tumino R, van der A DL, Sharp SJ, Langenberg C, Feskens EJ, Riboli E, Wareham NJ; InterAct Consortium. The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study. Am J Clin Nutr. 2012;96:382-390. doi: 10.3945/ajcn.111.021907.
59. O'Sullivan TA, Hafekost K, Mitrou F, Lawrence D. Food sources of saturated fat and the association with mortality: a meta-analysis. Am J Public Health. 2013;103:e31-e42. doi: 10.2105/AJPH.2013.301492.
60. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, Hotamisligil GS. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med. 2010;153:790-799. doi: 10.7326/0003-4819-153-12-201012210-00005.
61. Mozaffarian D, de Oliveira Otto MC, Lemaitre RN, Fretts AM, Hotamisligil G, Tsai MY, Siscovick DS, Nettleton JA. trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2013;97:854-861. doi: 10.3945/ajcn.112.045468.
62. Forouhi NG, Koulman A, Sharp SJ, Imamura F, Kröger J, Schulze MB, Crowe FL, Huerta JM, Guevara M, Beulens JW, van Woudenbergh GJ, Wang L, Summerhill K, Griffin JL, Feskens EJ, Amiano P, Boeing H, Clavel-Chapelon F, Dartois L, Fagherazzi G, Franks PW, Gonzalez C, Jakobsen MU, Kaaks R, Key TJ, Khaw KT, Kühn T, Mattiello A, Nilsson PM, Overvad K, Pala V, Palli D, Quirós JR, Rolandsson O, Roswall N, Sacerdote C, Sánchez MJ, Slimani N, Spijkerman AM, Tjonneland A, Tormo MJ, Tumino R, van der A DL, van der Schouw YT, Langenberg C, Riboli E, Wareham NJ. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol. 2014;2:810-818. doi: 10.1016/S2213-8587(14)70146-9.
63. Scharf RJ, Demmer RT, DeBoer MD. Longitudinal evaluation of milk type consumed and weight status in preschoolers. Arch Dis Child. 2013;98:335-340. doi: 10.1136/archdischild-2012-302941.
64. Noel SE, Ness AR, Northstone K, Emmett P, Newby PK. Associations between flavored milk consumption and changes in weight and body composition over time: differences among normal and overweight children. Eur J Clin Nutr. 2013;67:295-300. doi: 10.1038/ejcn.2012.123.
65. Huh SY, Rifas-Shiman SL, Rich-Edwards JW, Taveras EM, Gillman MW. Prospective association between milk intake and adiposity in preschoolaged children. J Am Diet Assoc. 2010;110:563-570. doi: 10.1016/j. jada.2009.12.025.
66. Berkey CS, Rockett HR, Willett WC, Colditz GA. Milk, dairy fat, dietary calcium, and weight gain: a longitudinal study of adolescents. Arch Pediatr Adolesc Med. 2005;159:543-550. doi: 10.1001/archpedi.159.6.543.
67. Noel SE, Ness AR, Northstone K, Emmett P, Newby PK. Milk intakes are not associated with percent body fat in children from ages 10 to 13 years. J Nutr. 2011;141:2035-2041. doi: 10.3945/jn.111.143420.
68. Gonnissen HK, Hulshof T, Westerterp-Plantenga MS. Chronobiology, endocrinology, and energy-and food-reward homeostasis. Obes Rev. 2013;14:405-416. doi: 10.1111/obr.12019.
69. Haines J, McDonald J, O'Brien A, Sherry B, Bottino CJ, Schmidt ME, Taveras EM. Healthy Habits, Happy Homes: randomized trial to improve household routines for obesity prevention among preschoolaged children. JAMA Pediatr. 2013;167:1072-1079. doi: 10.1001/jamapediatrics.2013.2356.
70. Corfe BM, Harden CJ, Bull M, Garaiova I. The multifactorial interplay of diet, the microbiome and appetite control: current knowledge and future challenges. Proc Nutr Soc. 2015:74:235-244XXX.
71. Catalano P, deMouzon SH. Maternal obesity and metabolic risk to the offspring: why lifestyle interventions may have not achieved the desired outcomes. Int J Obes (Lond). 2015;39:642-649. doi: 10.1038/ijo.2015.15.
72. Robinson TN. Reducing children's television viewing to prevent obesity: a randomized controlled trial. JAMA. 1999;282:1561-1567.
73. Epstein LH, Roemmich JN, Robinson JL, Paluch RA, Winiewicz DD, Fuerch JH, Robinson TN. A randomized trial of the effects of reducing television viewing and computer use on body mass index in young children. Arch Pediatr Adolesc Med. 2008;162:239-245. doi: 10.1001/archpediatrics.2007.45.
74. Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med. 2007;357:370-379. doi: 10.1056/NEJMsa066082.
75. Corella D, Ordovas JM. Nutrigenomics in cardiovascular medicine. Circ Cardiovasc Genet. 2009;2:637-651. doi: 10.1161/CIRCGENETICS.109.891366.
76. Kalantarian S, Rimm EB, Herrington DM, Mozaffarian D. Dietary macronutrients, genetic variation, and progression of coronary atherosclerosis among women. Am Heart J. 2014;167:627-635.e1. doi: 10.1016/j. ahj.2014.01.001.
77. Abdullah MM, Jones PJ, Eck PK. Nutrigenetics of cholesterol metabolism: observational and dietary intervention studies in the postgenomic era. Nutr Rev. 2015;73:523-543. doi: 10.1093/nutrit/nuv016.
78. Villegas R, Goodloe RJ, McClellan BE Jr, Boston J, Crawford DC. Gene-carbohydrate and gene-fiber interactions and type 2 diabetes in diverse populations from the National Health and Nutrition Examination Surveys (NHANES) as part of the Epidemiologic Architecture for Genes Linked to Environment (EAGLE) study. BMC Genet. 2014;15:69. doi: 10.1186/1471-2156-15-69.
79. Nettleton JA, Hivert MF, Lemaitre RN, McKeown NM, Mozaffarian D, Tanaka T, Wojczynski MK, Hruby A, Djoussé L, Ngwa JS, Follis JL, Dimitriou M, Ganna A, Houston DK, Kanoni S, Mikkilä V, Manichaikul A, Ntalla I, Renström F, Sonestedt E, van Rooij FJ, Bandinelli S, de Koning L, Ericson U, Hassanali N, Kiefte-de Jong JC, Lohman KK, Raitakari O, Papoutsakis C, Sjogren P, Stirrups K, Ax E, Deloukas P, Groves CJ, Jacques PF, Johansson I, Liu Y, McCarthy MI, North K, Viikari J, Zillikens MC, Dupuis J, Hofman A, Kolovou G, Mukamal K, Prokopenko I, Rolandsson O, Seppälä I, Cupples LA, Hu FB, Kähönen M, Uitterlinden AG, Borecki IB, Ferrucci L, Jacobs DR Jr, Kritchevsky SB, Orho-Melander M, Pankow JS, Lehtimäki T, Witteman JC, Ingelsson E, Siscovick DS, Dedoussis G, Meigs JB, Franks PW. Meta-analysis investigating associations between healthy diet and fasting glucose and insulin levels and modification by loci associated with glucose homeostasis in data from 15 cohorts. Am J Epidemiol. 2013;177:103-115. doi: 10.1093/aje/kws297.
80. Smith CE, Ngwa J, Tanaka T, Qi Q, Wojczynski MK, Lemaitre RN, Anderson JS, Manichaikul A, Mikkilä V, van Rooij FJ, Ye Z, Bandinelli S, Frazier-Wood AC, Houston DK, Hu F, Langenberg C, McKeown NM, Mozaffarian D, North KE, Viikari J, Zillikens MC, Djoussé L, Hofman A, Kähönen M, Kabagambe EK, Loos RJ, Saylor GB, Forouhi NG, Liu Y, Mukamal KJ, Chen YD, Tsai MY, Uitterlinden AG, Raitakari O, van Duijn CM, Arnett DK, Borecki IB, Cupples LA, Ferrucci L, Kritchevsky SB, Lehtimäki T, Qi L, Rotter JI, Siscovick DS, Wareham NJ, Witteman JC, Ordovás JM, Nettleton JA. Lipoprotein receptor-related protein 1 variants and dietary fatty acids: meta-analysis of European origin and African American studies. Int J Obes (Lond). 2013;37:1211-1220. doi: 10.1038/ijo.2012.215.
81. Tanaka T, Ngwa JS, van Rooij FJ, Zillikens MC, Wojczynski MK, Frazier-Wood AC, Houston DK, Kanoni S, Lemaitre RN, Luan J, Mikkilä V, Renstrom F, Sonestedt E, Zhao JH, Chu AY, Qi L, Chasman DI, de Oliveira Otto MC, Dhurandhar EJ, Feitosa MF, Johansson I, Khaw KT, Lohman KK, Manichaikul A, McKeown NM, Mozaffarian D, Singleton A, Stirrups K, Viikari J, Ye Z, Bandinelli S, Barroso I, Deloukas P, Forouhi NG, Hofman A, Liu Y, Lyytikäinen LP, North KE, Dimitriou M, Hallmans G, Kähönen M, Langenberg C, Ordovas JM, Uitterlinden AG, Hu FB, Kalafati IP, Raitakari O, Franco OH, Johnson A, Emilsson V, Schrack JA, Semba RD, Siscovick DS, Arnett DK, Borecki IB, Franks PW, Kritchevsky SB, Lehtimäki T, Loos RJ, Orho-Melander M, Rotter JI, Wareham NJ, Witteman JC, Ferrucci L, Dedoussis G, Cupples LA, Nettleton JA. Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake. Am J Clin Nutr. 2013;97:1395-1402. doi: 10.3945/ajcn.112.052183.
82. Qi Q, Kilpeläinen TO, Downer MK, Tanaka T, Smith CE, Sluijs I, Sonestedt E, Chu AY, Renström F, Lin X, Ängquist LH, Huang J, Liu Z, Li Y, Asif Ali M, Xu M, Ahluwalia TS, Boer JM, Chen P, Daimon M, Eriksson J, Perola M, Friedlander Y, Gao YT, Heppe DH, Holloway JW, Houston DK, Kanoni S, Kim YM, Laaksonen MA, Jääskeläinen T, Lee NR, Lehtimäki T, Lemaitre RN, Lu W, Luben RN, Manichaikul A, Männistö S, Marques-Vidal P, Monda KL, Ngwa JS, Perusse L, van Rooij FJ, Xiang YB, Wen W, Wojczynski MK, Zhu J, Borecki IB, Bouchard C, Cai Q, Cooper C, Dedoussis GV, Deloukas P, Ferrucci L, Forouhi NG, Hansen T, Christiansen L, Hofman A, Johansson I, Jørgensen T, Karasawa S, Khaw KT, Kim MK, Kristiansson K, Li H, Lin X, Liu Y, Lohman KK, Long J, Mikkilä V, Mozaffarian D, North K, Pedersen O, Raitakari O, Rissanen H, Tuomilehto J, van der Schouw YT, Uitterlinden AG, Zillikens MC, Franco OH, Shyong Tai E, Ou Shu X, Siscovick DS, Toft U, Verschuren WM, Vollenweider P, Wareham NJ, Witteman JC, Zheng W, Ridker PM, Kang JH, Liang L, Jensen MK, Curhan GC, Pasquale LR, Hunter DJ, Mohlke KL, Uusitupa M, Cupples LA, Rankinen T, Orho-Melander M, Wang T, Chasman DI, Franks PW, Sørensen TI, Hu FB, Loos RJ, Nettleton JA, Qi L. FTO genetic variants, dietary intake and body mass index: insights from 177,330 individuals. Hum Mol Genet. 2014;23:6961-6972. doi: 10.1093/hmg/ddu411.
83. Dashti HS, Follis JL, Smith CE, Tanaka T, Cade BE, Gottlieb DJ, Hruby A, Jacques PF, Lamon-Fava S, Richardson K, Saxena R, Scheer FA, Kovanen L, Bartz TM, Perälä MM, Jonsson A, Frazier-Wood AC, Kalafati IP, Mikkilä V, Partonen T, Lemaitre RN, Lahti J, Hernandez DG, Toft U, Johnson WC, Kanoni S, Raitakari OT, Perola M, Psaty BM, Ferrucci L, Grarup N, Highland HM, Rallidis L, Kähönen M, Havulinna AS, Siscovick DS, Räikkönen K, Jørgensen T, Rotter JI, Deloukas P, Viikari JS, Mozaffarian D, Linneberg A, Seppälä I, Hansen T, Salomaa V, Gharib SA, Eriksson JG, Bandinelli S, Pedersen O, Rich SS, Dedoussis G, Lehtimäki T, Ordovás JM. Habitual sleep duration is associated with BMI and macronutrient intake and may be modified by CLOCK genetic variants. Am J Clin Nutr. 2015;101:135-143. doi: 10.3945/ajcn.114.095026.
84. Smith CE, Follis JL, Nettleton JA, Foy M, Wu JH, Ma Y, Tanaka T, Manichakul AW, Wu H, Chu AY, Steffen LM, Fornage M, Mozaffarian D, Kabagambe EK, Ferruci L, Chen YD, Rich SS, Djoussé L, Ridker PM, Tang W, McKnight B, Tsai MY, Bandinelli S, Rotter JI, Hu FB, Chasman DI, Psaty BM, Arnett DK, King IB, Sun Q, Wang L, Lumley T, Chiuve SE, Siscovick DS, Ordovás JM, Lemaitre RN. Dietary fatty acids modulate associations between genetic variants and circulating fatty acids in plasma and erythrocyte membranes: meta-analysis of nine studies in the CHARGE consortium. Mol Nutr Food Res. 2015;59:1373-1383. doi: 10.1002/mnfr.201400734.
85. Goran MI, Walker R, Allayee H. Genetic-related and carbohydrate-related factors affecting liver fat accumulation. Curr Opin Clin Nutr Metab Care. 2012;15:392-396. doi: 10.1097/MCO.0b013e3283544477.
86. Sevastianova K, Santos A, Kotronen A, Hakkarainen A, Makkonen J, Silander K, Peltonen M, Romeo S, Lundbom J, Lundbom N, Olkkonen VM, Gylling H, FielDing BA, Rissanen A, Yki-Järvinen H. Effect of short-term carbohydrate overfeeDing and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr. 2012;96:727-734. doi: 10.3945/ajcn.112.038695.
87. Ebbeling CB, Feldman HA, Chomitz VR, Antonelli TA, Gortmaker SL, Osganian SK, Ludwig DS. A randomized trial of sugar-sweetened beverages and adolescent body weight. N Engl J Med. 2012;367:1407-1416. doi: 10.1056/NEJMoa1203388.
88. Santoro N, Savoye M, Kim G, Marotto K, Shaw MM, Pierpont B, Caprio S. Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake. PLoS One. 2012;7:e37827. doi: 10.1371/journal. pone.0037827.
89. Szarc vel Szic K, Declerck K, Vidakovi? M, Vanden Berghe W. From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition? Clin Epigenetics. 2015;7:33. doi: 10.1186/s13148-015-0068-2.
90. Mirrahimi A, de Souza RJ, Chiavaroli L, Sievenpiper JL, Beyene J, Hanley AJ, Augustin LS, Kendall CW, Jenkins DJ. Associations of glycemic index and load with coronary heart disease events: a systematic review and meta-analysis of prospective cohorts. J Am Heart Assoc. 2012;1:e000752. doi: 10.1161/JAHA.112.000752.
91. Gardner CD. Tailoring dietary approaches for weight loss. Int J Obes Suppl. 2012;2(suppl 1):S11-S15. doi: 10.1038/ijosup.2012.4.
92. Thomas DE, Elliott EJ. The use of low-glycaemic index diets in diabetes control. Br J Nutr. 2010;104:797-802. doi: 10.1017/S0007114510001534.
93. Dong JY, Zhang ZL, Wang PY, Qin LQ. Effects of high-protein diets on body weight, glycaemic control, blood lipids and blood pressure in type 2 diabetes: meta-analysis of randomised controlled trials. Br J Nutr. 2013;110:781-789. doi: 10.1017/S0007114513002055.
94. Viana LV, Gross JL, Azevedo MJ. Dietary intervention in patients with gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials on maternal and newborn outcomes. Diabetes Care. 2014;37:3345-3355. doi: 10.2337/dc14-1530.
95. Artinian NT, Fletcher GF, Mozaffarian D, Kris-Etherton P, Van Horn L, Lichtenstein AH, Kumanyika S, Kraus WE, Fleg JL, Redeker NS, Meininger JC, Banks J, Stuart-Shor EM, Fletcher BJ, Miller TD, Hughes S, Braun LT, Kopin LA, Berra K, Hayman LL, Ewing LJ, Ades PA, Durstine JL, Houston-Miller N, Burke LE; American Heart Association Prevention Committee of the Council on Cardiovascular Nursing. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation. 2010;122:406-441. doi: 10.1161/CIR.0b013e3181e8edf1.
96. Spring B, Ockene JK, GidDing SS, Mozaffarian D, Moore S, Rosal MC, Brown MD, Vafiadis DK, Cohen DL, Burke LE, Lloyd-Jones D; American Heart Association Behavior Change Committee of the Council on Epidemiology and Prevention, Council on Lifestyle and Cardiometabolic Health, Council for High Blood Pressure Research, and Council on Cardiovascular and Stroke Nursing. Better population health through behavior change in adults: a call to action. Circulation. 2013;128:2169-2176. doi: 10.1161/01.cir.0000435173.25936.e1.
97. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793-795. doi: 10.1056/NEJMp1500523.
98. Capewell S, O'Flaherty M. Rapid mortality falls after risk-factor changes in populations. Lancet. 2011;378:752-753. doi: 10.1016/S0140-6736(10)62302-1.
99. McGill R, Anwar E, Orton L, Bromley H, Lloyd-Williams F, O'Flaherty M, Taylor-Robinson D, Guzman-Castillo M, Gillespie D, Moreira P, Allen K, Hyseni L, Calder N, Petticrew M, White M, Whitehead M, Capewell S. Are interventions to promote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact. BMC Public Health. 2015;15:457. doi: 10.1186/s12889-015-1781-7.
100. Guzman-Castillo M, Ahmed R, Hawkins N, Scholes S, Wilkinson E, Lucy J, Capewell S, O'Flaherty M. The contribution of primary prevention medication and dietary change in coronary mortality reduction in England between 2000 and 2007: a modelling study. BMJ open. 2015;5:e006070
101. Hoffman R, Gerber M. Food processing and the Mediterranean diet. Nutrients. 2015;7:7925-7964. doi: 10.3390/nu7095371.
102. Louzada ML, Baraldi LG, Steele EM, Martins AP, Canella DS, Moubarac JC, Levy RB, Cannon G, Afshin A, Imamura F, Mozaffarian D, Monteiro CA. Consumption of ultra-processed foods and obesity in Brazilian adolescents and adults. Prev Med. 2015;81:9-15. doi: 10.1016/j.ypmed.2015.07.018.
103. Dobarganes C, Márquez-Ruiz G. Possible adverse effects of frying with vegetable oils. Br J Nutr. 2015;113(suppl 2):S49-S57. doi: 10.1017/S0007114514002347.
104. Monteiro CA, Moubarac JC, Cannon G, Ng SW, Popkin B. Ultraprocessed products are becoming dominant in the global food system. Obes Rev. 2013;14 Suppl 2:21-28. doi: 10.1111/obr.12107.
105. Ford JA, MacLennan GS, Avenell A, Bolland M, Grey A, Witham M; RECORD Trial Group. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr. 2014;100:746-755. doi: 10.3945/ajcn.113.082602.
106. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842-857. doi: 10.1001/jama.297.8.842.
107. Miller ER 3rd, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37-46.
108. Miller ER 3rd, Juraschek S, Pastor-Barriuso R, Bazzano LA, Appel LJ, Guallar E. Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels. Am J Cardiol. 2010;106:517-527. doi: 10.1016/j. amjcard.2010.03.064.
109. Huang HY, Caballero B, Chang S, Alberg AJ, Semba RD, Schneyer CR, Wilson RF, Cheng TY, Vassy J, Prokopowicz G, Barnes GJ 2nd, Bass EB. The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference. Ann Intern Med. 2006;145:372-385.
110. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012;308:1024-1033. doi: 10.1001/2012.jama.11374.
111. Dietary Guidelines Advisory Committee. 2010 Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans. 2010. http://www.cnpp.usda.gov/DGAs2010-DGACReport. htm. Accessed September 26, 2010.
112. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167:1730-1737. doi: 10.1001/archinte.167.16.1730.
113. Mozaffarian D. UpToDate: Fish oil and marine omega-3 fatty acids. 2010. http://www.uptodate.com/patients/content/topic. do?topicKey=~P22PNBTmTumdat. Accessed October 13, 2010.
114. Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691.
115. Basu A, Rhone M, Lyons TJ. Berries: emerging impact on cardiovascular health. Nutr Rev. 2010;68:168-177. doi: 10.1111/j.1753-4887.2010.00273.x.
116. Huang WY, Davidge ST, Wu J. Bioactive natural constituents from food sources-potential use in hypertension prevention and treatment. Crit Rev Food Sci Nutr. 2013;53:615-630. doi: 10.1080/10408398.2010.550071.
117. Gylling H, Plat J, Turley S, Ginsberg HN, Ellegård L, Jessup W, Jones PJ, Lütjohann D, Maerz W, Masana L, Silbernagel G, Staels B, Borén J, Catapano AL, De Backer G, Deanfield J, Descamps OS, Kovanen PT, Riccardi G, Tokgözoglu L, Chapman MJ; European Atherosclerosis Society Consensus Panel on Phytosterols. Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease. Atherosclerosis. 2014;232:346-360. doi: 10.1016/j. atherosclerosis.2013.11.043.
118. Mirmiran P, Bahadoran Z, Azizi F. Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: a review. World J Diabetes. 2014;5:267-281. doi: 10.4239/wjd.v5.i3.267.
119. Mehta N, Ahlawat SS, Sharma DP, Dabur RS. Novel trends in development of dietary fiber rich meat products-a critical review. J Food Sci Technol. 2015;52:633-647. doi: 10.1007/s13197-013-1010-2.
120. Bhat ZF, Kumar S, Bhat HF. Bioactive peptides of animal origin: a review. J Food Sci Technol. 2015;52:5377-5392. doi: 10.1007/s13197-015-1731-5.
121. Ryan PM, Ross RP, Fitzgerald GF, Caplice NM, Stanton C. Functional food addressing heart health: do we have to target the gut microbiota? Curr Opin Clin Nutr Metab Care. 2015;18:566-571. doi: 10.1097/MCO.0000000000000224.
122. Sharma S, Puri S. Prebiotics and lipid metabolism: a review. Altern Ther Health Med. 2015;21(suppl 3):34-42.
123. Vergès B, Fumeron F. Potential risks associated with increased plasma plant-sterol levels. Diabetes Metab. 2015;41:76-81. doi: 10.1016/j. diabet.2014.11.003.
124. Weingärtner O, Teupser D, Patel SB. The atherogenicity of plant sterols: the evidence from genetics to clinical trials. J AOAC Int. 2015;98:742-749. doi: 10.5740/jaoacint.SGEWeingartner.
125. Dangour AD, Dodhia SK, Hayter A, Allen E, Lock K, Uauy R. Nutritional quality of organic foods: a systematic review. Am J Clin Nutr. 2009;90:680-685. doi: 10.3945/ajcn.2009.28041.
126. Smith-Spangler C, Brandeau ML, Hunter GE, Bavinger JC, Pearson M, Eschbach PJ, Sundaram V, Liu H, Schirmer P, Stave C, Olkin I, Bravata DM. Are organic foods safer or healthier than conventional alternatives?: a systematic review. Ann Intern Med. 2012;157:348-366. doi: 10.7326/0003-4819-157-5-201209040-00007.
127. Bara?ski M, Srednicka-Tober D, Volakakis N, Seal C, Sanderson R, Stewart GB, Benbrook C, Biavati B, Markellou E, Giotis C, Gromadzka-Ostrowska J, Rembia?kowska E, Skwar?o-So?ta K, Tahvonen R, Janovská D, Niggli U, Nicot P, Leifert C. Higher antioxidant and lower cadmium concentrations and lower incidence of pesticide residues in organically grown crops: a systematic literature review and meta-analyses. Br J Nutr. 2014;112:794-811. doi: 10.1017/S0007114514001366.
128. Dangour AD, Lock K, Hayter A, Aikenhead A, Allen E, Uauy R. Nutrition-related health effects of organic foods: a systematic review. Am J Clin Nutr. 2010;92:203-210. doi: 10.3945/ajcn.2010.29269.
129. Zacka A, Bügel S, Paoletti F, Kahl J, Bonanno A, Dostalova A, Rahmann G. The influence of organic production on food quality-research findings, gaps and future challenges. J Sci Food Agric. 2014;94:2600-2604. doi: 10.1002/jsfa.6578.
130. Johansson E, Hussain A, Kuktaite R, Andersson SC, Olsson ME. Contribution of organically grown crops to human health. Int J Environ Res Public Health. 2014;11:3870-3893. doi: 10.3390/ijerph110403870.
131. American Medical Association. AMA Report on Genetically Modified Crops and Foods 2001. https://www.isaaa.org/kc/Publications/htm/articles/Position/ama.htm. Accessed July 16, 2015.
132. Key S, Ma JK, Drake PM. Genetically modified plants and human health. J R Soc Med. 2008;101:290-298. doi: 10.1258/jrsm.2008.070372.
133. American Association for the Advancement of Science. Statement by the AAAS Board of Directors On Labeling of Genetically Modified Foods. 2013. http://www.aaas.org/sites/default/files/AAAS-GM
134. World Health Organization. Frequently asked questions on genetically modified foods. 2014. http://www.who.int/foodsafety/areas-work/food-technology/Frequently-asked-questions-on-gm-foods.pdf?ua=1. Accessed July 16, 2015.
135. Van Eenennaam AL, Young AE. Prevalence and impacts of genetically engineered feedstuffs on livestock populations. J Anim Sci. 2014;92:4255-4278. doi: 10.2527/jas.2014-8124.
136. Domingo JL, Giné Bordonaba J. A literature review on the safety assessment of genetically modified plants. Environ Int. 2011;37:734-742. doi: 10.1016/j.envint.2011.01.003.
137. Hammond B, Kough J, Herouet-Guicheney C, Jez JM; ILSI International Food Biotechnology Committee Task Force on Use of Mammalian Toxicology Studies in Safety Assessment of GM Foods. Toxicological evaluation of proteins introduced into food crops. Crit Rev Toxicol. 2013;43(suppl 2):25-42. doi: 10.3109/10408444.2013.842956.
138. Bartholomaeus A, Parrott W, Bondy G, Walker K; ILSI International Food Biotechnology Committee Task Force on Use of Mammalian Toxicology Studies in Safety Assessment of GM Foods. The use of whole food animal studies in the safety assessment of genetically modified crops: limitations and recommendations. Crit Rev Toxicol. 2013;43 Suppl 2:1-24. doi: 10.3109/10408444.2013.842955.
139. Nicolia A, Manzo A, Veronesi F, Rosellini D. An overview of the last 10 years of genetically engineered crop safety research. Crit Rev Biotechnol. 2014;34:77-88. doi: 10.3109/07388551.2013.823595.
140. Devos Y, Aguilera J, Diveki Z, Gomes A, Liu Y, Paoletti C, du Jardin P, Herman L, Perry JN, Waigmann E. EFSA's scientific activities and achievements on the risk assessment of genetically modified organisms (GMOs) during its first decade of existence: looking back and ahead. Transgenic Res. 2014;23:1-25. doi: 10.1007/s11248-013-9741-4.
141. Institute of Medicine. Safety of Genetically Modified Foods: Approaches to Assessing Unintended Health Effects. Washington DC: The National Academies Press; 2004.
142. Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation. 2010;121:2271-2283. doi: 10.1161/CIRCULATIONAHA.109.924977.
143. Gan Y, Tong X, Li L, Cao S, Yin X, Gao C, Herath C, Li W, Jin Z, Chen Y, Lu Z. Consumption of fruit and vegetable and risk of coronary heart disease: a meta-analysis of prospective cohort studies. Int J Cardiol. 2015;183:129-137. doi: 10.1016/j.ijcard.2015.01.077.
144. Hu D, Huang J, Wang Y, Zhang D, Qu Y. Fruits and vegetables consumption and risk of stroke: a meta-analysis of prospective cohort studies. Stroke. 2014;45:1613-1619. doi: 10.1161/STROKEAHA.114.004836.
145. Li M, Fan Y, Zhang X, Hou W, Tang Z. Fruit and vegetable intake and risk of type 2 diabetes mellitus: meta-analysis of prospective cohort studies. BMJ Open. 2014;4:e005497. doi: 10.1136/bmjopen-2014-005497.
146. Afshin A, Micha R, Khatibzadeh S, Mozaffarian D. Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 2014;100:278-288. doi: 10.3945/ajcn.113.076901.
147. Halton TL, Willett WC, Liu S, Manson JE, Stampfer MJ, Hu FB. Potato and french fry consumption and risk of type 2 diabetes in women. Am J Clin Nutr. 2006;83:284-290.
148. Heidari-Beni M, Golshahi J, Esmaillzadeh A, Azadbakht L. Potato consumption as high glycemic index food, blood pressure, and body mass index among Iranian adolescent girls. ARYA Atheroscler. 2015;11(suppl 1):81-87.
149. Khosravi-Boroujeni H, Mohammadifard N, Sarrafzadegan N, Sajjadi F, Maghroun M, Khosravi A, Alikhasi H, Rafieian M, Azadbakht L. Potato consumption and cardiovascular disease risk factors among Iranian population. Int J Food Sci Nutr. 2012;63:913-920. doi: 10.3109/09637486.2012.690024.
150. Khosravi-Boroujeni H, Saadatnia M, Shakeri F, Keshteli AH, Esmaillzadeh A. A case-control study on potato consumption and risk of stroke in central Iran. Arch Iran Med. 2013;16:172-176. doi: 013163/AIM.009.
151. Manwa B, Kashongwe Z, Bahindwa B, Kolanowski J, Hermans MP. Dietary cassava, beta-cell function and hyperbolic product loss rate in type 2 diabetes patients from South Kivu. Diabetes Metab. 2010;36:108-113. doi: 10.1016/j.diabet.2009.08.001.
152. Rosa ML, Falcão PM, Yokoo EM, da Cruz Filho RA, Alcoforado VM, de Souza Bda S, Pinto FN, Nery AB. Brazil's staple food and incident diabetes. Nutrition. 2014;30:365-368. doi: 10.1016/j.nut.2013.09.004.
153. Tang G, Wang D, Long J, Yang F, Si L. Meta-analysis of the association between whole grain intake and coronary heart disease risk. Am J Cardiol. 2015;115:625-629. doi: 10.1016/j.amjcard.2014.12.015.
154. Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab Cardiovasc Dis. 2008;18:283-290. doi: 10.1016/j.numecd.2006.12.008.
155. Aune D, Norat T, Romundstad P, Vatten LJ. Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Eur J Epidemiol. 2013;28:845-858. doi: 10.1007/s10654-013-9852-5.
156. Jakobsen MU, O'Reilly EJ, Heitmann BL, Pereira MA, Bälter K, Fraser GE, Goldbourt U, Hallmans G, Knekt P, Liu S, Pietinen P, Spiegelman D, Stevens J, Virtamo J, Willett WC, Ascherio A. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89:1425-1432. doi: 10.3945/ajcn.2008.27124.
157. Cai X, Wang C, Wang S, Cao G, Jin C, Yu J, Li X, Yan J, Wang F, Yu W, Ding F. Carbohydrate intake, glycemic index, glycemic load, and stroke: a meta-analysis of prospective cohort studies. Asia Pac J Public Health. 2015;27:486-496. doi: 10.1177/1010539514566742.
158. Alhazmi A, Stojanovski E, McEvoy M, Garg ML. Macronutrient intakes and development of type 2 diabetes: a systematic review and meta-analysis of cohort studies. J Am Coll Nutr. 2012;31:243-258.
159. Bhupathiraju SN, Tobias DK, Malik VS, Pan A, Hruby A, Manson JE, Willett WC, Hu FB. Glycemic index, glycemic load, and risk of type 2 diabetes: results from 3 large US cohorts and an updated meta-analysis. Am J Clin Nutr. 2014;100:218-232. doi: 10.3945/ajcn.113.079533.
160. Wu Y, Qian Y, Pan Y, Li P, Yang J, Ye X, Xu G. Association between dietary fiber intake and risk of coronary heart disease: a meta-analysis. Clin Nutr. 2015;34:603-611. doi: 10.1016/j.clnu.2014.05.009.
161. Yao B, Fang H, Xu W, Yan Y, Xu H, Liu Y, Mo M, Zhang H, Zhao Y. Dietary fiber intake and risk of type 2 diabetes: a dose-response analysis of prospective studies. Eur J Epidemiol. 2014;29:79-88. doi: 10.1007/s10654-013-9876-x.
162. Atkinson FS, Foster-Powell K, Brand-Miller JC. International tables of glycemic index and glycemic load values: 2008. Diabetes Care. 2008;31:2281-2283. doi: 10.2337/dc08-1239.
163. Lê KA, Bortolotti M. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2008;11:477-482. doi: 10.1097/MCO.0b013e328302f3e.c.
164. Gower BA, Goss AM. A lower-carbohydrate, higher-fat diet reduces abdominal and intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes. J Nutr. 2015;145:177S-183S. doi: 10.3945/jn.114.195065.
165. Basaranoglu M, Basaranoglu G, Sabuncu T, Sentürk H. Fructose as a key player in the development of fatty liver disease. World J Gastroenterol. 2013;19:1166-1172. doi: 10.3748/wjg.v19.i8.1166.
166. Stanhope KL. Sugar consumption, metabolic disease and obesity: the state of the controversy [published online ahead of print September 17, 2015]. Crit Rev Clin Lab Sci. doi: 10.3109/10408363.2015.1084990. Accessed October 11, 2015. http://www.tandfonline.com/doi/abs/10.31 09/10408363.2015.1084990?journalCode=ilab20
167. Malik VS, Hu FB. Fructose and cardiometabolic health: what the evidence from sugar-sweetened beverages tells us. J Am Coll Cardiol. 2015;66:1615-1624. doi: 10.1016/j.jacc.2015.08.025.
168. Fan J, Song Y, Wang Y, Hui R, Zhang W. Dietary glycemic index, glycemic load, and risk of coronary heart disease, stroke, and stroke mortality: a systematic review with meta-analysis. PLoS One. 2012;7:e52182. doi: 10.1371/journal.pone.0052182.
169. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD; American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586-613. doi: 10.1161/CIRCULATIONAHA.109.192703.
170. Mozaffarian RS, Lee RM, Kennedy MA, Ludwig DS, Mozaffarian D, Gortmaker SL. Identifying whole grain foods: a comparison of different approaches for selecting more healthful whole grain products. Public Health Nutr. 2013;16:2255-2264.
171. Sinha R, Cross AJ, Graubard BI, Leitzmann MF, Schatzkin A. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med. 2009;169:562-571. doi: 10.1001/archinternmed.2009.6.
172. Bernstein AM, Sun Q, Hu FB, Stampfer MJ, Manson JE, Willett WC. Major dietary protein sources and risk of coronary heart disease in women. Circulation. 2010;122:876-883. doi: 10.1161/CIRCULATIONAHA.109.915165.
173. Pan A, Sun Q, Bernstein AM, Schulze MB, Manson JE, Willett WC, Hu FB. Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. Am J Clin Nutr. 2011;94:1088-1096. doi: 10.3945/ajcn.111.018978.
174. Chen GC, Lv DB, Pang Z, Liu QF. Red and processed meat consumption and risk of stroke: a meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2013;67:91-95. doi: 10.1038/ejcn.2012.180.
175. Abete I, Romaguera D, Vieira AR, Lopez de Munain A, Norat T. Association between total, processed, red and white meat consumption and all-cause, CVD and IHD mortality: a meta-analysis of cohort studies. Br J Nutr. 2014;112:762-775. doi: 10.1017/S000711451400124X.
176. Mozaffarian D. Meat intake and mortality: evidence for harm, no effect, or benefit? Arch Intern Med. 2009;169:1537-1538; author reply 1539. doi: 10.1001/archinternmed.2009.277.
177. Al-Solaiman Y, Jesri A, Mountford WK, Lackland DT, Zhao Y, Egan BM. DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens. 2010;24:237-246. doi: 10.1038/jhh.2009.58.
178. Tang WH, Hazen SL. The contributory role of gut microbiota in cardiovascular disease. J Clin Invest. 2014;124:4204-4211. doi: 10.1172/JCI72331.
179. Bendinelli B, Palli D, Masala G, Sharp SJ, Schulz MB, Guevara M, van der AD, Sera F, Amiano P, Balkau B, Barricarte A, Boeing H, Crowe FL, Dahm CC, Dalmeijer G, de Lauzon-Guillain B, Egeberg R, Fagherazzi G, Franks PW, Krogh V, Huerta JM, Jakszyn P, Khaw KT, Li K, Mattiello A, Nilsson PM, Overvad K, Ricceri F, Rolandsson O, Sanchez MJ, Slimani N, Sluijs I, Spijkerman AM, Teucher B, Tjonneland A, Tumino R, van den Berg SW, Forouhi NG, Langeberg C, Feskens EJ, Riboli E, Wareham NJ. Association between dietary meat consumption and incident type 2 diabetes: the EPIC-InterAct study. Diabetologia. 2013;56:47-59
180. Swaminathan S, Fonseca VA, Alam MG, Shah SV. The role of iron in diabetes and its complications. Diabetes Care. 2007;30:1926-1933. doi: 10.2337/dc06-2625.
181. Zhao Z, Li S, Liu G, Yan F, Ma X, Huang Z, Tian H. Body iron stores and heme-iron intake in relation to risk of type 2 diabetes: a systematic review and meta-analysis. PLoS One. 2012;7:e41641. doi: 10.1371/journal. pone.0041641.
182. Wittenbecher C, Mühlenbruch K, Kröger J, Jacobs S, Kuxhaus O, Floegel A, Fritsche A, Pischon T, Prehn C, Adamski J, Joost HG, Boeing H, Schulze MB. Amino acids, lipid metabolites, and ferritin as potential mediators linking red meat consumption to type 2 diabetes. Am J Clin Nutr. 2015;101:1241-1250. doi: 10.3945/ajcn.114.099150.
183. Kim Y, Keogh J, Clifton P. A review of potential metabolic etiologies of the observed association between red meat consumption and development of type 2 diabetes mellitus. Metabolism. 2015;64:768-779. doi: 10.1016/j.metabol.2015.03.008.
184. Micha R, Michas G, Lajous M, Mozaffarian D. Processing of meats and cardiovascular risk: time to focus on preservatives. BMC Med. 2013;11:136. doi: 10.1186/1741-7015-11-136.
185. Daley CA, Abbott A, Doyle PS, Nader GA, Larson S. A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef. Nutr J. 2010;9:10. doi: 10.1186/1475-2891-9-10.
186. Van Elswyk ME, McNeill SH. Impact of grass/forage feeDing versus grain finishing on beef nutrients and sensory quality: the U.S. experience. Meat Sci. 2014;96:535-540. doi: 10.1016/j.meatsci.2013.08.010.
187. Nagao M, Iso H, Yamagishi K, Date C, Tamakoshi A. Meat consumption in relation to mortality from cardiovascular disease among Japanese men and women. Eur J Clin Nutr. 2012;66:687-693. doi: 10.1038/ejcn.2012.6.
188. Takata Y, Shu XO, Gao YT, Li H, Zhang X, Gao J, Cai H, Yang G, Xiang YB, Zheng W. Red meat and poultry intakes and risk of total and cause-specific mortality: results from cohort studies of Chinese adults in Shanghai. PLoS One. 2013;8:e56963. doi: 10.1371/journal. pone.0056963.
189. Lee JE, McLerran DF, Rolland B, Chen Y, Grant EJ, Vedanthan R, Inoue M, Tsugane S, Gao YT, Tsuji I, Kakizaki M, Ahsan H, Ahn YO, Pan WH, Ozasa K, Yoo KY, Sasazuki S, Yang G, Watanabe T, Sugawara Y, Parvez F, Kim DH, Chuang SY, Ohishi W, Park SK, Feng Z, Thornquist M, Boffetta P, Zheng W, Kang D, Potter J, Sinha R. Meat intake and causespecific mortality: a pooled analysis of Asian prospective cohort studies. Am J Clin Nutr. 2013;98:1032-1041. doi: 10.3945/ajcn.113.062638.
190. Haring B, Gronroos N, Nettleton JA, von Ballmoos MC, Selvin E, Alonso A. Dietary protein intake and coronary heart disease in a large community based cohort: results from the Atherosclerosis Risk in Communities (ARIC) study [corrected]. PLoS One. 2014;9:e109552. doi: 10.1371/journal.pone.0109552.
191. van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care. 2002;25:417-424.
192. Montonen J, Järvinen R, Heliövaara M, Reunanen A, Aromaa A, Knekt P. Food consumption and the incidence of type II diabetes mellitus. Eur J Clin Nutr. 2005;59:441-448. doi: 10.1038/sj.ejcn.1602094.
193. Villegas R, Shu XO, Gao YT, Yang G, Cai H, Li H, Zheng W. The association of meat intake and the risk of type 2 diabetes may be modified by body weight. Int J Med Sci. 2006;3:152-159.
194. Männistö S, Kontto J, Kataja-Tuomola M, Albanes D, Virtamo J. High processed meat consumption is a risk factor of type 2 diabetes in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention study. Br J Nutr. 2010;103:1817-1822. doi: 10.1017/S0007114510000073.
195. Steinbrecher A, Erber E, Grandinetti A, Kolonel LN, Maskarinec G. Meat consumption and risk of type 2 diabetes: the Multiethnic Cohort. Public Health Nutr. 2011;14:568-574. doi: 10.1017/S1368980010002004.
196. Kurotani K, Nanri A, Goto A, Mizoue T, Noda M, Oba S, Kato M, Matsushita Y, Inoue M, Tsugane S; Japan Public Health Center-based Prospective Study Group. Red meat consumption is associated with the risk of type 2 diabetes in men but not in women: a Japan Public Health Center-based Prospective Study. Br J Nutr. 2013;110:1910-1918. doi: 10.1017/S0007114513001128.
197. Rong Y, Chen L, Zhu T, Song Y, Yu M, Shan Z, Sands A, Hu FB, Liu L. Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies. BMJ. 2013;346:e8539.
198. Shin JY, Xun P, Nakamura Y, He K. Egg consumption in relation to risk of cardiovascular disease and diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 2013;98:146-159. doi: 10.3945/ajcn.112.051318.
199. Ding EL, Mozaffarian D. Optimal dietary habits for the prevention of stroke. Semin Neurol. 2006;26:11-23. doi: 10.1055/s-2006-933305.
200. Iso H. Lifestyle and cardiovascular disease in Japan. J Atheroscler Thromb. 2011;18:83-88.
201. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296:1885-1899. doi: 10.1001/jama.296.15.1885.
202. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58:2047-2067. doi: 10.1016/j.jacc.2011.06.063.
203. Zheng J, Huang T, Yu Y, Hu X, Yang B, Li D. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutr. 2012;15:725-737. doi: 10.1017/S1368980011002254.
204. Larsson SC, Orsini N, Wolk A. Long-chain omega-3 polyunsaturated fatty acids and risk of stroke: a meta-analysis. Eur J Epidemiol. 2012;27:895-901. doi: 10.1007/s10654-012-9748-9.
205. Leung Yinko SS, Stark KD, Thanassoulis G, Pilote L. Fish consumption and acute coronary syndrome: a meta-analysis. Am J Med. 2014;127:848-57.e2. doi: 10.1016/j.amjmed.2014.04.016.
206. Wu JH, Mozaffarian D. 3 fatty acids, atherosclerosis progression and cardiovascular outcomes in recent trials: new pieces in a complex puzzle. Heart. 2014;100:530-533. doi: 10.1136/heartjnl-2013-305257.
207. Pradhan AD, Manson JE. Update on the Vitamin D and OmegA-3 trial (VITAL) [published online ahead of print April 9, 2015]. J Steroid Biochem Mol Biol. doi: 10.1016/j.jsbmb.2015.04.006. Accessed October 11, 2015. http://www.sciencedirect.com/science/article/pii/S096007601500103X
208. Chowdhury R, Stevens S, Gorman D, Pan A, Warnakula S, Chowdhury S, Ward H, Johnson L, Crowe F, Hu FB, Franco OH. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ. 2012;345:e6698.
209. Mozaffarian D, Wu JH, de Oliveira Otto MC, Sandesara CM, Metcalf RG, Latini R, Libby P, Lombardi F, O'Gara PT, Page RL, Silletta MG, Tavazzi L, Marchioli R. Fish oil and post-operative atrial fibrillation: a meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2013;61:2194-2196. doi: 10.1016/j.jacc.2013.02.045.
210. Zheng JS, Huang T, Yang J, Fu YQ, Li D. Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis. PLoS One. 2012;7:e44525. doi: 10.1371/journal.pone.0044525.
211. Zhou Y, Tian C, Jia C. Association of fish and n-3 fatty acid intake with the risk of type 2 diabetes: a meta-analysis of prospective studies. Br J Nutr. 2012;108:408-417. doi: 10.1017/S0007114512002036.
212. Wu JH, Micha R, Imamura F, Pan A, Biggs ML, Ajaz O, Djousse L, Hu FB, Mozaffarian D. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis. Br J Nutr. 2012;107(suppl 2):S214-S227. doi: 10.1017/S0007114512001602.
213. Wu JH, Cahill LE, Mozaffarian D. Effect of fish oil on circulating adiponectin: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2013;98:2451-2459. doi: 10.1210/jc.2012-3899.
214. Turyk M, Anderson H, Knobeloch L, Imm P, Persky V. Organochlorine exposure and incidence of diabetes in a cohort of Great Lakes sport fish consumers. Environ Health Perspect. 2009;117:1076-1082. doi: 10.1289/ehp.0800281.
215. Bergkvist C, Berglund M, Glynn A, Wolk A, Åkesson A. Dietary exposure to polychlorinated biphenyls and risk of myocardial infarction-a population-based prospective cohort study. Int J Cardiol. 2015;183:242-248. doi: 10.1016/j.ijcard.2015.01.055.
216. Song Y, Chou EL, Baecker A, You NY, Sun Q, Liu S. Endocrinedisrupting chemicals, risk of type 2 diabetes, and diabetes-related metabolic traits: a systematic review and meta-analysis [published online ahead of print June 29, 2015]. J Diabetes. doi: 10.1111/1753-0407.12325. Accessed October 11, 2015. http://onlinelibrary.wiley.com.
217. Wolff E, Dansinger ML. Soft drinks and weight gain: how strong is the link? Medscape J Med. 2008;10:189.
218. Mozaffarian D, Shi P, Morris JS, Grandjean P, Siscovick DS, Spiegelman D, Willett WC, Rimm EB, Curhan GC, Forman JP. Mercury exposure and risk of hypertension in US men and women in 2 prospective cohorts. Hypertension. 2012;60:645-652. doi: 10.1161/HYPERTENSIONAHA.112.196154.
219. Mozaffarian D, Shi P, Morris JS, Grandjean P, Siscovick DS, Spiegelman D, Hu FB. Methylmercury exposure and incident diabetes in U.S. men and women in two prospective cohorts. Diabetes Care. 2013;36:3578-3584. doi: 10.2337/dc13-0894.
220. US Food And Drug Administration, US Environmental Protection Agency. Fish: What Pregnant Women and Parents Should Know. 2014. http://www.fda.gov/downloads/Food/FoodborneIllnessContaminants/Metals/UCM400358.pdf. Accessed May 27, 2015.
221. National Oceanic and Atmospheric Administration. NOAA Fish Watch: The suprising sources of your favorite seafoods. 2011. http://www. fishwatch.gov/features/top10seafoods-and-sources-10-10-12.html. Accessed July 16, 2015.
222. Soedamah-Muthu SS, Verberne LD, Ding EL, Engberink MF, Geleijnse JM. Dairy consumption and incidence of hypertension: a doseresponse meta-analysis of prospective cohort studies. Hypertension. 2012;60:1131-1137. doi: 10.1161/HYPERTENSIONAHA.112.195206.
223. Hu D, Huang J, Wang Y, Zhang D, Qu Y. Dairy foods and risk of stroke: a meta-analysis of prospective cohort studies. Nutr Metab Cardiovasc Dis. 2014;24:460-469. doi: 10.1016/j.numecd.2013.12.006.
224. Qin LQ, Xu JY, Han SF, Zhang ZL, Zhao YY, Szeto IM. Dairy consumption and risk of cardiovascular disease: an updated meta-analysis of prospective cohort studies. Asia Pac J Clin Nutr. 2015;24:90-100.
225. Gao D, Ning N, Wang C, Wang Y, Li Q, Meng Z, Liu Y, Li Q. Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis. PLoS One. 2013;8:e73965. doi: 10.1371/journal.pone.0073965.
226. Aune D, Norat T, Romundstad P, Vatten LJ. Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr. 2013;98:1066-1083. doi: 10.3945/ajcn.113.059030.
227. Chen M, Sun Q, Giovannucci E, Mozaffarian D, Manson JE, Willett WC, Hu FB. Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. BMC Med. 2014;12:215. doi: 10.1186/s12916-014-0215-1.
228. Ericson U, Hellstrand S, Brunkwall L, Schulz CA, Sonestedt E, Wallström P, Gullberg B, Wirfält E, Orho-Melander M. Food sources of fat may clarify the inconsistent role of dietary fat intake for incidence of type 2 diabetes. Am J Clin Nutr. 2015;101:1065-1080. doi: 10.3945/ajcn.114.103010.
229. Diaz-Lopez A, Bullo M, Martinez-Gonzalez MA, Corella D, Estruch R, Fito M, Gomez-Gracia E, Fiol M, Garcia de la Corte FJ, Ros E, Babio N, Serra-Majem L, Pinto X, Munoz MA, Frances F, Buil-Cosiales P, Salas-Salvado J. Dairy product consumption and risk of type 2 diabetes in an elderly Spanish Mediterranean population at high cardiovascular risk [published online ahead of print February 7, 2015]. Eur J Nutr. doi:10.1007/s00394-015-0855-8. Accessed October 11, 2015. http://link.springer.com/article/10.1007%2Fs00394-015-0855-8
230. Nestel PJ, Mellett N, Pally S, Wong G, Barlow CK, Croft K, Mori TA, Meikle PJ. Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults. Br J Nutr. 2013;110:2242-2249. doi: 10.1017/S0007114513001621.
231. Walther B, Karl JP, Booth SL, Boyaval P. Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements. Adv Nutr. 2013;4:463-473. doi: 10.3945/an.113.003855.
232. Choi HJ, Yu J, Choi H, An JH, Kim SW, Park KS, Jang HC, Kim SY, Shin CS. Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: a placebo-controlled trial. Diabetes Care. 2011;34:e147. doi: 10.2337/dc11-0551.
233. Chen M, Pan A, Malik VS, Hu FB. Effects of dairy intake on body weight and fat: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012;96:735-747. doi: 10.3945/ajcn.112.037119.
234. Abargouei AS, Janghorbani M, Salehi-Marzijarani M, Esmaillzadeh A. Effect of dairy consumption on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials. Int J Obes (Lond). 2012;36:1485-1493. doi: 10.1038/ijo.2011.269.
235. Niinikoski H, Viikari J, Rönnemaa T, Helenius H, Jokinen E, Lapinleimu H, Routi T, Lagström H, Seppänen R, Välimäki I, Simell O. Regulation of growth of 7-to 36-month-old children by energy and fat intake in the prospective, randomized STRIP baby trial. Pediatrics. 1997;100:810-816.
236. Nupponen M, Pahkala K, Juonala M, Magnussen CG, Niinikoski H, Rönnemaa T, Viikari JS, Saarinen M, Lagström H, Jula A, Simell O, Raitakari OT. Metabolic syndrome from adolescence to early adulthood: effect of infancy-onset dietary counseling of low saturated fat: the Special Turku Coronary Risk Factor Intervention Project (STRIP). Circulation. 2015;131:605-613. doi: 10.1161/CIRCULATIONAHA.114.010532.
237. Kadooka Y, Sato M, Imaizumi K, Ogawa A, Ikuyama K, Akai Y, Okano M, Kagoshima M, Tsuchida T. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr. 2010;64:636-643. doi: 10.1038/ejcn.2010.19.
238. Sharafedtinov KK, Plotnikova OA, Alexeeva RI, Sentsova TB, Songisepp E, Stsepetova J, Smidt I, Mikelsaar M. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients-a randomized double-blind placebo-controlled pilot study. Nutr J. 2013;12:138. doi: 10.1186/1475-2891-12-138.
239. Jung SP, Lee KM, Kang JH, Yun SI, Park HO, Moon Y, Kim JY. Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: a randomized, double-blind clinical trial. Korean J Fam Med. 2013;34:80-89. doi: 10.4082/kjfm.2013.34.2.80.
240. Kadooka Y, Sato M, Ogawa A, Miyoshi M, Uenishi H, Ogawa H, Ikuyama K, Kagoshima M, Tsuchida T. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. Br J Nutr. 2013;110:1696-1703. doi: 10.1017/S0007114513001037.
241. Sanchez M, Darimont C, Drapeau V, Emady-Azar S, Lepage M, Rezzonico E, Ngom-Bru C, Berger B, Philippe L, Ammon-Zuffrey C, Leone P, Chevrier G, St-Amand E, Marette A, Doré J, Tremblay A. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr. 2014;111:1507-1519. doi: 10.1017/S0007114513003875.
242. Barrett HL, Dekker Nitert M, Conwell LS, Callaway LK. Probiotics for preventing gestational diabetes. Cochrane Database Syst Rev. 2014;2:CD009951. doi: 10.1002/14651858.CD009951.pub2.
243. Kratz M, Baars T, Guyenet S. The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Nutr. 2013;52:1-24. doi: 10.1007/s00394-012-0418-1.
244. Kratz M, Marcovina S, Nelson JE, Yeh MM, Kowdley KV, Callahan HS, Song X, Di C, Utzschneider KM. Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not ?-cell function in humans. Am J Clin Nutr. 2014;99:1385-1396. doi: 10.3945/ajcn.113.075457.
245. Khaw KT, Friesen MD, Riboli E, Luben R, Wareham N. Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study. PLoS Med. 2012;9:e1001255. doi: 10.1371/journal.pmed.1001255.
246. de Oliveira Otto MC, Nettleton JA, Lemaitre RN, Steffen LM, Kromhout D, Rich SS, Tsai MY, Jacobs DR, Mozaffarian D. Biomarkers of dairy fatty acids and risk of cardiovascular disease in the Multi-ethnic Study of Atherosclerosis. J Am Heart Assoc. 2013;2:e000092. doi: 10.1161/JAHA.113.000092.
247. Yakoob MY, Shi P, Hu FB, Campos H, Rexrode KM, Orav EJ, Willett WC, Mozaffarian D. Circulating biomarkers of dairy fat and risk of incident stroke in U.S. men and women in 2 large prospective cohorts. Am J Clin Nutr. 2014;100:1437-1447. doi: 10.3945/ajcn.114.083097.
248. Mozaffarian D. Natural trans fat, dairy fat, partially hydrogenated oils, and cardiometabolic health: the Ludwigshafen Risk and Cardiovascular Health Study [published online ahead of print November 18, 2015]. Eur Heart J. doi: 10.1093/eurheartj/ehv595. Accessed October 11, 2015. http://eurheartj.oxfordjournals.org/content/early/2015/11/17/eurheartj.ehv595
249. Buijsse B, Boeing H, Drogan D, Schulze MB, Feskens EJ, Amiano P, Barricarte A, Clavel-Chapelon F, de Lauzon-Guillain B, Fagherazzi G, Fonseca-Nunes A, Franks PW, Huerta JM, Jakobsen MU, Kaaks R, Key TJ, Khaw KT, Masala G, Moskal A, Nilsson PM, Overvad K, Pala V, Panico S, Redondo ML, Ricceri F, Rolandsson O, Sánchez MJ, Sluijs I, Spijkerman AM, Tjonneland A, Tumino R, van der A DL, van der Schouw YT, Langenberg C, Sharp SJ, Forouhi NG, Riboli E, Wareham NJ; InterAct Consortium. Consumption of fatty foods and incident type 2 diabetes in populations from eight European countries. Eur J Clin Nutr. 2015;69:455-461. doi: 10.1038/ejcn.2014.249.
250. Janu C, Kumar DRS, Reshma MV, Jayamurthy P, Sundaresan A, Nisha P. Comparative study on the total phenolic content and radical scavenging activity of common edible vegetable oils. J Food Biochem. 2014;38:38-49.
251. Tresserra-Rimbau A, Rimm EB, Medina-Remón A, Martínez-González MA, de la Torre R, Corella D, Salas-Salvadó J, Gómez-Gracia E, Lapetra J, Arós F, Fiol M, Ros E, Serra-Majem L, Pintó X, Saez GT, Basora J, Sorlí JV, Martínez JA, Vinyoles E, Ruiz-Gutiérrez V, Estruch R, Lamuela-Raventós RM; PREDIMED Study Investigators. Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the PREDIMED study. Nutr Metab Cardiovasc Dis. 2014;24:639-647. doi: 10.1016/j.numecd.2013.12.014.
252. Scotece M, Conde J, Abella V, Lopez V, Pino J, Lago F, Smith AB 3rd, Gómez-Reino JJ, Gualillo O. New drugs from ancient natural foods. Oleocanthal, the natural occurring spicy compound of olive oil: a brief history. Drug Discov Today. 2015;20:406-410. doi: 10.1016/j.drudis.2014.10.017.
253. Beauchamp GK, Keast RS, Morel D, Lin J, Pika J, Han Q, Lee CH, Smith AB, Breslin PA. Phytochemistry: ibuprofen-like activity in extravirgin olive oil. Nature. 2005;437:45-46. doi: 10.1038/437045a.
254. Fernando WM, Martins IJ, Goozee KG, Brennan CS, Jayasena V, Martins RN. The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action. Br J Nutr. 2015;114:1-14. doi: 10.1017/S0007114515001452.
255. Hayes KC, Pronczuk A. Replacing trans fat: the argument for palm oil with a cautionary note on interesterification. J Am Coll Nutr. 2010;29:253S-284S
256. Jones PJ, Senanayake VK, Pu S, Jenkins DJ, Connelly PW, Lamarche B, Couture P, Charest A, Baril-Gravel L, West SG, Liu X, Fleming JA, McCrea CE, Kris-Etherton PM. DHA-enriched high-oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trial. Am J Clin Nutr. 2014;100:88-97. doi: 10.3945/ajcn.113.081133.
257. Hu FB. Resolved: there is sufficient scientific evidence that decreasing sugar-sweetened beverage consumption will reduce the prevalence of obesity and obesity-related diseases. Obes Rev. 2013;14:606-619. doi: 10.1111/obr.12040.
258. Imamura F, O'Connor L, Ye Z, Mursu J, Hayashino Y, Bhupathiraju SN, Forouhi NG. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. BMJ. 2015;351:h3576.
259. Xi B, Huang Y, Reilly KH, Li S, Zheng R, Barrio-Lopez MT, Martinez-Gonzalez MA, Zhou D. Sugar-sweetened beverages and risk of hypertension and CVD: a dose-response meta-analysis. Br J Nutr. 2015;113:709-717. doi: 10.1017/S0007114514004383.
260. Singh GM, Micha R, Khatibzadeh S, Shi P, Lim S, Andrews KG, Engell RE, Ezzati M, Mozaffarian D, Global Burden of Diseases Nutrition and Chronic Diseases Expert Group. Global, regional, and national consumption levels of sugar-sweetened beverages, fruit juices, and milk: a systematic analysis incluDing 195 country-specific nutrition surveys worldwide. PLoS One. 2015;10:e0124845. doi: 10.1371/journal. pone.0124845.
261. Singh GM, Micha R, Khatibzadeh S, Lim S, Ezzati M, Mozaffarian D, on behalf of the Global Burden of Diseases Nutrition and Chronic Diseases Expert Group. Estimated global, regional, and national disease burdens related to sugar-sweetened beverage consumption in 2010. Circulation. 2015;132:639-666. doi: 10.1161/CIRCULATIONAHA.114.010636.
262. Raben A, Richelsen B. Artificial sweeteners: a place in the field of functional foods? Focus on obesity and related metabolic disorders. Curr Opin Clin Nutr Metab Care. 2012;15:597-604. doi: 10.1097/MCO.0b013e328359678a.
263. Swithers SE, Martin AA, Davidson TL. High-intensity sweeteners and energy balance. Physiol Behav. 2010;100:55-62. doi: 10.1016/j. physbeh.2009.12.021.
264. Shankar P, Ahuja S, Sriram K. Non-nutritive sweeteners: review and update. Nutrition. 2013;29:1293-1299. doi: 10.1016/j.nut.2013.03.024.
265. Burke MV, Small DM. Physiological mechanisms by which nonnutritive sweeteners may impact body weight and metabolism. Physiol Behav. 2015;152(pt B):381-388. doi: 10.1016/j.physbeh.2015.05.036.
266. Pepino MY. Metabolic effects of non-nutritive sweeteners. Physiol Behav. 2015;152(pt B):450-455. doi: 10.1016/j.physbeh.2015.06.024.
267. Xi B, Li S, Liu Z, Tian H, Yin X, Huai P, Tang W, Zhou D, Steffen LM. Intake of fruit juice and incidence of type 2 diabetes: a systematic review and meta-analysis. PLoS One. 2014;9:e93471. doi: 10.1371/journal. pone.0093471.
268. Liu K, Xing A, Chen K, Wang B, Zhou R, Chen S, Xu H, Mi M. Effect of fruit juice on cholesterol and blood pressure in adults: a meta-analysis of 19 randomized controlled trials. PLoS One. 2013;8:e61420. doi: 10.1371/journal.pone.0061420.
269. Wang B, Liu K, Mi M, Wang J. Effect of fruit juice on glucose control and insulin sensitivity in adults: a meta-analysis of 12 randomized controlled trials. PLoS One. 2014;9:e95323. doi: 10.1371/journal. pone.0095323.
270. Ding M, Bhupathiraju SN, Chen M, van Dam RM, Hu FB. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care. 2014;37:569-586. doi: 10.2337/dc13-1203.
271. Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Longterm coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2014;129:643-659. doi: 10.1161/CIRCULATIONAHA.113.005925.
272. Wedick NM, Brennan AM, Sun Q, Hu FB, Mantzoros CS, van Dam RM. Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J. 2011;10:93. doi: 10.1186/1475-2891-10-93.
273. Ohnaka K, Ikeda M, Maki T, Okada T, Shimazoe T, Adachi M, Nomura M, Takayanagi R, Kono S. Effects of 16-week consumption of caffeinated and decaffeinated instant coffee on glucose metabolism in a randomized controlled trial. J Nutr Metab. 2012;2012:207426. doi: 10.1155/2012/207426.
274. Steffen M, Kuhle C, Hensrud D, Erwin PJ, Murad MH. The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis. J Hypertens. 2012;30:2245-2254. doi: 10.1097/HJH.0b013e3283588d73.
275. Nordestgaard AT, Thomsen M, Nordestgaard BG. Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study. Int J Epidemiol. 2015;44:551-565. doi: 10.1093/ije/dyv083.
276. Yang WS, Wang WY, Fan WY, Deng Q, Wang X. Tea consumption and risk of type 2 diabetes: a dose-response meta-analysis of cohort studies. Br J Nutr. 2014;111:1329-1339. doi: 10.1017/S0007114513003887.
277. Zhang C, Qin YY, Wei X, Yu FF, Zhou YH, He J. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol. 2015;30:103-113. doi: 10.1007/s10654-014-9960-x.
278. Zheng XX, Xu YL, Li SH, Hui R, Wu YJ, Huang XH. Effects of green tea catechins with or without caffeine on glycemic control in adults: a metaanalysis of randomized controlled trials. Am J Clin Nutr. 2013;97:750-762. doi: 10.3945/ajcn.111.032573.
279. Li Y, Wang C, Huai Q, Guo F, Liu L, Feng R, Sun C. Effects of tea or tea extract on metabolic profiles in patients with type 2 diabetes mellitus: a meta-analysis of 10 randomized controlled trials [published ahead of print February 17, 2015]. Diabetes Metab Res Rev. doi: 10.1002/dmrr.2641. Accessed October 11, 2015. http://onlinelibrary.wiley.com.
280. Liu G, Mi XN, Zheng XX, Xu YL, Lu J, Huang XH. Effects of tea intake on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr. 2014;112:1043-1054. doi: 10.1017/S0007114514001731.
281. Yarmolinsky J, Gon G, Edwards P. Effect of tea on blood pressure for secondary prevention of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2015;73:236-246. doi: 10.1093/nutrit/nuv001.
282. Serban C, Sahebkar A, Ursoniu S, Andrica F, Banach M. Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: a systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2015;33:1119-1127. doi: 10.1097/HJH.0000000000000585.
283. Aziz Z, Wong SY, Chong NJ. Effects of Hibiscus sabdariffa L. on serum lipids: a systematic review and meta-analysis. J Ethnopharmacol. 2013;150:442-450. doi: 10.1016/j.jep.2013.09.042.
284. Onakpoya I, Spencer E, Heneghan C, Thompson M. The effect of green tea on blood pressure and lipid profile: a systematic review and metaanalysis of randomized clinical trials. Nutr Metab Cardiovasc Dis. 2014;24:823-836. doi: 10.1016/j.numecd.2014.01.016.
285. Wang D, Chen C, Wang Y, Liu J, Lin R. Effect of black tea consumption on blood cholesterol: a meta-analysis of 15 randomized controlled trials. PLoS One. 2014;9:e107711. doi: 10.1371/journal.pone.0107711.
286. Laonigro I, Correale M, Di Biase M, Altomare E. Alcohol abuse and heart failure. Eur J Heart Fail. 2009;11:453-462. doi: 10.1093/eurjhf/hfp037.
287. Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol. 2014;64:281-289. doi: 10.1016/j.jacc.2014.03.048.
288. Núñez-Córdoba JM, Valencia-Serrano F, Toledo E, Alonso A, Martínez-González MA. The Mediterranean diet and incidence of hypertension: the Seguimiento Universidad de Navarra (SUN) Study. Am J Epidemiol. 2009;169:339-346. doi: 10.1093/aje/kwn335.
289. Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, Rehm J. Alcohol as a risk factor for type 2 diabetes: a systematic review and metaanalysis. Diabetes Care. 2009;32:2123-2132. doi: 10.2337/dc09-0227.
290. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.
291. Willcox BJ, Willcox DC, Todoriki H, Fujiyoshi A, Yano K, He Q, Curb JD, Suzuki M. Caloric restriction, the traditional Okinawan diet, and healthy aging: the diet of the world's longest-lived people and its potential impact on morbidity and life span. Ann N Y Acad Sci. 2007;1114:434-455. doi: 10.1196/annals.1396.037.
292. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ. 2011;342:d636.
293. Arranz S, Chiva-Blanch G, Valderas-Martínez P, Medina-Remón A, Lamuela-Raventós RM, Estruch R. Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients. 2012;4:759-781. doi: 10.3390/nu4070759.
294. Bagnardi V, Zatonski W, Scotti L, La Vecchia C, Corrao G. Does drinking pattern modify the effect of alcohol on the risk of coronary heart disease? Evidence from a meta-analysis. J Epidemiol Community Health. 2008;62:615-619. doi: 10.1136/jech.2007.065607.
295. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, Ezzati M. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6:e1000058. doi: 10.1371/journal.pmed.1000058.
296. Shrime MG, Bauer SR, McDonald AC, Chowdhury NH, Coltart CE, Ding EL. Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J Nutr. 2011;141:1982-1988. doi: 10.3945/jn.111.145482.
297. Corti R, Flammer AJ, Hollenberg NK, Lüscher TF. Cocoa and cardiovascular health. Circulation. 2009;119:1433-1441. doi: 10.1161/CIRCULATIONAHA.108.827022.
298. Hooper L, Kay C, Abdelhamid A, Kroon PA, Cohn JS, Rimm EB, Cassidy A. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr. 2012;95:740-751. doi: 10.3945/ajcn.111.023457.
299. Taubert D, Roesen R, Lehmann C, Jung N, Schömig E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA. 2007;298:49-60. doi: 10.1001/jama.298.1.49.
300. Perez-Vizcaino F, Duarte J. Flavonols and cardiovascular disease. Mol Aspects Med. 2010;31:478-494. doi: 10.1016/j.mam.2010.09.002.
301. Buitrago-Lopez A, Sanderson J, Johnson L, Warnakula S, Wood A, Di Angelantonio E, Franco OH. Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ. 2011;343:d4488.
302. Basu A, Lyons TJ. Strawberries, blueberries, and cranberries in the metabolic syndrome: clinical perspectives. J Agric Food Chem. 2012;60:5687-5692. doi: 10.1021/jf203488k.
303. Brown IJ, Tzoulaki I, Candeias V, Elliott P. Salt intakes around the world: implications for public health. Int J Epidemiol. 2009;38:791-813. doi: 10.1093/ije/dyp139.
304. Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, Engell RE, Lim S, Danaei G, Mozaffarian D, On behalf of the Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE). Global, regional, and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3:e003733
305. Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, Lim S, Danaei G, Ezzati M, Powles J; Global Burden of Diseases Nutrition and Chronic Diseases Expert Group. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371:624-634. doi: 10.1056/NEJMoa1304127.
306. Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of lower sodium intake on health: systematic review and metaanalyses. BMJ. 2013;346:f1326.
307. Poggio R, Gutierrez L, Matta MG, Elorriaga N, Irazola V, Rubinstein A. Daily sodium consumption and CVD mortality in the general population: systematic review and meta-analysis of prospective studies. Public Health Nutr. 2015;18:695-704. doi: 10.1017/S1368980014000949.
308. Li XY, Cai XL, Bian PD, Hu LR. High salt intake and stroke: meta-analysis of the epidemiologic evidence. CNS Neurosci Ther. 2012;18:691-701. doi: 10.1111/j.1755-5949.2012.00355.x.
309. Institute of Medicine. Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Washington, DC: National Academies Press; 2010.
310. Sacks FM, Campos H. Dietary therapy in hypertension. N Engl J Med. 2010;362:2102-2112. doi: 10.1056/NEJMct0911013.
311. Susic D, Frohlich ED. Salt consumption and cardiovascular, renal, and hypertensive diseases: clinical and mechanistic aspects. Curr Opin Lipidol. 2012;23:11-16. doi: 10.1097/MOL.0b013e32834d9c52.
312. O'Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, Yan H, Lee SF, Mony P, Devanath A, Rosengren A, Lopez-Jaramillo P, Diaz R, Avezum A, Lanas F, Yusoff K, Iqbal R, Ilow R, Mohammadifard N, Gulec S, Yusufali AH, Kruger L, Yusuf R, Chifamba J, Kabali C, Dagenais G, Lear SA, Teo K, Yusuf S; PURE Investigators. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371:612-623. doi: 10.1056/NEJMoa1311889.
313. Kalogeropoulos AP, Georgiopoulou VV, Murphy RA, Newman AB, Bauer DC, Harris TB, Yang Z, Applegate WB, Kritchevsky SB. Dietary sodium content, mortality, and risk for cardiovascular events in older adults: the Health, Aging, and Body Composition (Health ABC) Study. JAMA Intern Med. 2015;175:410-419. doi: 10.1001/jamainternmed.2014.6278.
314. Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, Dunbar SB, Frohlich ED, Hall JE, Jessup M, Labarthe DR, MacGregor GA, Sacks FM, Stamler J, Vafiadis DK, Van Horn LV. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012;126:2880-2889. doi: 10.1161/CIR.0b013e318279acbf.
315. Strom BL, Anderson CA, Ix JH. Sodium reduction in populations: Insights from the Institute of Medicine Committee. JAMA. 2013:1-2
316. Cobb LK, Anderson CA, Elliott P, Hu FB, Liu K, Neaton JD, Whelton PK, Woodward M, Appel LJ; American Heart Association Council on Lifestyle and Metabolic Health. Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association. Circulation. 2014;129:1173-1186. doi: 10.1161/CIR.0000000000000015.
317. Guenther PM, Lyon JM, Appel LJ. Modeling dietary patterns to assess sodium recommendations for nutrient adequacy. Am J Clin Nutr. 2013;97:842-847. doi: 10.3945/ajcn.112.047779.
318. Cook NR, Appel LJ, Whelton PK. Lower levels of sodium intake and reduced cardiovascular risk. Circulation. 2014;129:981-989. doi: 10.1161/CIRCULATIONAHA.113.006032.
319. INTERSALT Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988;297:319-328
320. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PH; DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3-10. doi: 10.1056/NEJM200101043440101.
321. National Institute for Health and Clinical Excellence. Prevention of Cardiovascular Disease at Population Level (NICE Public Health Guidance 25). London: National Institute for Health and Clinical Excellence; 2010.
322. Dietary Guidelines for Americans, 2010. Washington, DC: US Department of Agriculture, US Department of Health and Human Services; 2010
323. World Health Organization. WHO Guideline: Sodium Intake For Adults and Children. Geneva, Switzerland: WHO; 2012.
324. Scientific Advisory Committee on Nutrition. Salt and Health. London: The Stationery Office; 2003.
325. Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev. 2011:CD004022.
326. Binia A, Jaeger J, Hu Y, Singh A, Zimmermann D. Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials. J Hypertens. 2015;33:1509-1520. doi: 10.1097/HJH.0000000000000611.
327. D'Elia L, Barba G, Cappuccio FP, Strazzullo P. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies. J Am Coll Cardiol. 2011;57:1210-1219. doi: 10.1016/j.jacc.2010.09.070.
328. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PH; DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3-10. doi: 10.1056/NEJM200101043440101.
329. Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ. 2011;342:d2040.
330. Mao PJ, Zhang C, Tang L, Xian YQ, Li YS, Wang WD, Zhu XH, Qiu HL, He J, Zhou YH. Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. Int J Cardiol. 2013;169:106-111. doi: 10.1016/j.ijcard.2013.08.055.
331. Del Gobbo LC, Imamura F, Wu JH, de Oliveira Otto MC, Chiuve SE, Mozaffarian D. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2013;98:160-173. doi: 10.3945/ajcn.112.053132.
332. Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659-669. doi: 10.1001/archinternmed.2009.38.
333. Ye Y, Li J, Yuan Z. Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS One. 2013;8:e56803. doi: 10.1371/journal.pone.0056803.
334. Proposed Changes to the Nutrition Facts Label. Silver Spring, MD: US Food and Drug Administration; 2015
335. Ludwig DS. Examining the health effects of fructose. JAMA. 2013;310:33-34. doi: 10.1001/jama.2013.6562.
336. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: The National Academies Press; 2002.
337. Mozaffarian D, Ludwig DS. The 2015 US Dietary Guidelines: lifting the ban on total dietary fat. JAMA. 2015;313:2421-2422. doi: 10.1001/jama.2015.5941.
338. Gallup. Americans Still Avoid Fat More Than Carbs. 2015. Accessed January 10, 2015. http://www.gallup.com/poll/174176/americans-avoidfat-carbs.aspx.
339. Malik VS, Chiuve SE, Campos H, Rimm EB, Mozaffarian D, Hu FB, Sun Q. Circulating very-long-chain saturated fatty acids and incident coronary heart disease in US men and women. Circulation. 2015;132:260-268. doi: 10.1161/CIRCULATIONAHA.114.014911.
340. Lemaitre RN, Fretts AM, Sitlani CM, Biggs ML, Mukamal K, King IB, Song X, Djoussé L, Siscovick DS, McKnight B, Sotoodehnia N, Kizer JR, Mozaffarian D. Plasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the Cardiovascular Health Study. Am J Clin Nutr. 2015;101:1047-1054. doi: 10.3945/ajcn.114.101857.
341. Mozaffarian D. Diverging global trends in heart disease and type 2 diabetes: the role of carbohydrates and saturated fats. Lancet Diabetes Endocrinol. 2015;3:586-588.
342. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77:1146-1155.
343. Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A; European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010;31:2844-2853. doi: 10.1093/eurheartj/ehq386.
344. Berglund L, Lefevre M, Ginsberg HN, Kris-Etherton PM, Elmer PJ, Stewart PW, Ershow A, Pearson TA, Dennis BH, Roheim PS, Ramakrishnan R, Reed R, Stewart K, Phillips KM; DELTA Investigators. Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr. 2007;86:1611-1620.
345. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010;91:502-509.
346. Moran B, Harvard T. H. Is butter really back? Clarying the facts on fat. Chan School of Public Health Magazine. 2014. http://www.hsph.harvard. edu/magazine-features/is-butter-really-back/. Accessed May 29, 2015.
347. Micha R, Khatibzadeh S, Shi P, Fahimi S, Lim S, Andrews KG, Engell RE, Powles J, Ezzati M, Mozaffarian D, on behalf of the Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE). Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis incluDing 266 country-specific nutrition surveys. BMJ. 2014;348:g2272.
348. Bandosz P, O'Flaherty M, Rutkowski M, Kypridemos C, Guzman-Castillo M, Gillespie DO, Solnica B, Pencina MJ, Wyrzykowski B, Capewell S, Zdrojewski T. A victory for statins or a defeat for diet policies? Cholesterol falls in Poland in the past decade: a modeling study. Int J Cardiol. 2015;185:313-319. doi: 10.1016/j.ijcard.2015.03.079.
349. Kypridemos C, Bandosz P, Hickey GL, Guzman-Castillo M, Allen K, Buchan I, Capewell S, O'Flaherty M. Quantifying the contribution of statins to the decline in population mean cholesterol by socioeconomic group in England 1991-2012: a modelling study. PLoS One. 2015;10:e0123112.
350. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7:e1000252. doi: 10.1371/journal.pmed.1000252.
351. Farvid MS, Ding M, Pan A, Sun Q, Chiuve SE, Steffen LM, Willett WC, Hu FB. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation. 2014;130:1568-1578. doi: 10.1161/CIRCULATIONAHA.114.010236.
352. Jakobsen MU, Dethlefsen C, Joensen AM, Stegger J, Tjønneland A, Schmidt EB, Overvad K. Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am J Clin Nutr. 2010;91:1764-1768. doi: 10.3945/ajcn.2009.29099.
353. Schwingshackl L, Hoffmann G. Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies. Lipids Health Dis. 2014;13:154. doi: 10.1186/1476-511X-13-154.
354. Schwingshackl L, Strasser B, Hoffmann G. Effects of monounsaturated fatty acids on cardiovascular risk factors: a systematic review and metaanalysis. Ann Nutr Metab. 2011;59:176-186. doi: 10.1159/000334071.
355. Schwingshackl L, Strasser B, Hoffmann G. Effects of monounsaturated fatty acids on glycaemic control in patients with abnormal glucose metabolism: a systematic review and meta-analysis. Ann Nutr Metab. 2011;58:290-296. doi: 10.1159/000331214.
356. Micha R, Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids. 2010;45:893-905. doi: 10.1007/s11745-010-3393-4.
357. Degirolamo C, Shelness GS, Rudel LL. LDL cholesteryl oleate as a predictor for atherosclerosis: evidence from human and animal studies on dietary fat. J Lipid Res. 2009;50(suppl):S434-S439. doi: 10.1194/jlr. R800076-JLR200.
358. Jones PJ, MacKay DS, Senanayake VK, Pu S, Jenkins DJ, Connelly PW, Lamarche B, Couture P, Kris-Etherton PM, West SG, Liu X, Fleming JA, Hantgan RR, Rudel LL. High-oleic canola oil consumption enriches LDL particle cholesteryl oleate content and reduces LDL proteoglycan binDing in humans. Atherosclerosis. 2015;238:231-238. doi: 10.1016/j. atherosclerosis.2014.12.010.
359. Lands WE. Dietary fat and health: the evidence and the politics of prevention: careful use of dietary fats can improve life and prevent disease. Ann N Y Acad Sci. 2005;1055:179-192. doi: 10.1196/annals.1323.028.
360. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation. 2003;108:155-160. doi: 10.1161/01.CIR.0000079224.46084.C2.
361. Poudel-Tandukar K, Nanri A, Matsushita Y, Sasaki S, Ohta M, Sato M, Mizoue T. Dietary intakes of alpha-linolenic and linoleic acids are inversely associated with serum C-reactive protein levels among Japanese men. Nutr Res. 2009;29:363-370. doi: 10.1016/j.nutres.2009.05.012.
362. Kalogeropoulos N, Panagiotakos DB, Pitsavos C, Chrysohoou C, Rousinou G, Toutouza M, Stefanadis C. Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin Chim Acta. 2010;411:584-591. doi: 10.1016/j.cca.2010.01.023.
363. Johnson GH, Fritsche K. Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials. J Acad Nutr Diet. 2012;112:1029-1041, 1041.e1. doi: 10.1016/j.jand.2012.03.029.
364. Keys A, Menotti A, Karvonen MJ, Aravanis C, Blackburn H, Buzina R, Djordjevic BS, Dontas AS, Fidanza F, Keys MH. The diet and 15-year death rate in the seven countries study. Am J Epidemiol. 1986;124:903-915.
365. Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ, Engler MM, Engler MB, Sacks F. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation. 2009;119:902-907. doi: 10.1161/CIRCULATIONAHA.108.191627.
366. Jebb SA, Lovegrove JA, Griffin BA, Frost GS, Moore CS, Chatfield MD, Bluck LJ, Williams CM, Sanders TA; RISCK Study Group. Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am J Clin Nutr. 2010;92:748-758. doi: 10.3945/ajcn.2009.29096.
367. Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L, Berglund J, Pulkki K, Basu S, Uusitupa M, Rudling M, Arner P, Cederholm T, Ahlström H, Risérus U. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr. 2012;95:1003-1012. doi: 10.3945/ajcn.111.030114.
368. Rosqvist F, Iggman D, Kullberg J, Cedernaes J, Johansson HE, Larsson A, Johansson L, Ahlström H, Arner P, Dahlman I, Risérus U. OverfeeDing polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes. 2014;63:2356-2368. doi: 10.2337/db13-1622.
369. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349-361. doi: 10.1038/nri2294.
370. Spite M, Clària J, Serhan CN. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab. 2014;19:21-36. doi: 10.1016/j.cmet.2013.10.006.
371. Joint FAO/WHO Expert Consultation on the Risks and Benefits of Fish Consumption. Executive Summary. 2010. ftp://ftp.fao.org/FI/DOCUMENT/risk-consumption/executive-summary.pdf. Accessed May 21, 2010.
372. Geleijnse JM, de Goede J, Brouwer IA. Alpha-linolenic acid: is it essential to cardiovascular health? Curr Atheroscler Rep. 2010;12:359-367. doi: 10.1007/s11883-010-0137-0.
373. Pan A, Chen M, Chowdhury R, Wu JH, Sun Q, Campos H, Mozaffarian D, Hu FB. Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr. 2012;96:1262-1273. doi: 10.3945/ajcn.112.044040.
374. Kromhout D, Giltay EJ, Geleijnse JM; Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010;363:2015-2026. doi: 10.1056/NEJMoa1003603.
375. Griffin BA. How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Curr Opin Lipidol. 2008;19:57-62. doi: 10.1097/MOL.0b013e3282f2e2a8.
376. Mozaffarian D, Aro A, Willett WC. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr. 2009;63(suppl 2):S5-S21. doi: 10.1038/sj.ejcn.1602973.
377. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601-1613. doi: 10.1056/NEJMra054035.
378. Howard BV, Manson JE, Stefanick ML, Beresford SA, Frank G, Jones B, Rodabough RJ, Snetselaar L, Thomson C, Tinker L, Vitolins M, Prentice R. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA. 2006;295:39-49. doi: 10.1001/jama.295.1.39.
379. Micha R, Mozaffarian D. Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol. 2009;5:335-344. doi: 10.1038/nrendo.2009.79.
380. Wallace SK, Mozaffarian D. Trans-fatty acids and nonlipid risk factors. Curr Atheroscler Rep. 2009;11:423-433.
381. Lambelet P, Grandgirard A, Gregoire S, Juaneda P, Sebedio JL, Bertoli C. Formation of modified fatty acids and oxyphytosterols during refining of low erucic acid rapeseed oil. J Agric Food Chem. 2003;51:4284-4290. doi: 10.1021/jf030091u.
382. Velasco J, Marmesat S, Bordeaux O, Márquez-Ruiz G, Dobarganes C. Formation and evolution of monoepoxy fatty acids in thermoxidized olive and sunflower oils and quantitation in used frying oils from restaurants and fried-food outlets. J Agric Food Chem. 2004;52:4438-4443. doi: 10.1021/jf030753f.
383. United Nations. Draft Outcome Document of the High-level Meeting on the Prevention and Control of Non-communicable Diseases. 2011. Accessed October 11, 2015. http://www.ncdalliance.org/sites/default/files/resource-files/UN%20High-Level%20Summit%20Zero%20Draft.pdf.
384. Frieden TR, Berwick DM. The "Million Hearts" initiative-preventing heart attacks and strokes. N Engl J Med. 2011;365:e27. doi: 10.1056/NEJMp1110421.
385. US Food and Drug Administration. FDA Cuts Trans Fat in Processed Foods. 2015. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm372915.htm. Accessed July 16, 2015.
386. Schwingshackl L, Hoffmann G. Long-term effects of low-fat diets either low or high in protein on cardiovascular and metabolic risk factors: a systematic review and meta-analysis. Nutr J. 2013;12:48. doi: 10.1186/1475-2891-12-48.
387. Nilsson LM, Winkvist A, Eliasson M, Jansson JH, Hallmans G, Johansson I, Lindahl B, Lenner P, Van Guelpen B. Low-carbohydrate, high-protein score and mortality in a northern Swedish populationbased cohort. Eur J Clin Nutr. 2012;66:694-700. doi: 10.1038/ejcn.2012.9.
388. Brug J. Determinants of healthy eating: motivation, abilities and environmental opportunities. Fam Pract. 2008;25(suppl 1):i50-i55. doi: 10.1093/fampra/cmn063.
389. van't Riet J, Sijtsema SJ, Dagevos H, De Bruijn GJ. The importance of habits in eating behaviour. An overview and recommendations for future research. Appetite. 2011;57:585-596. doi: 10.1016/j.appet.2011.07.010.
390. Patel SR, Hu FB. Short sleep duration and weight gain: a systematic review. Obesity (Silver Spring). 2008;16:643-653. doi: 10.1038/oby.2007.118.
391. Brug J, Kremers SP, Lenthe Fv, Ball K, Crawford D. Environmental determinants of healthy eating: in need of theory and evidence. Proc Nutr Soc. 2008;67:307-316. doi: 10.1017/S0029665108008616.
392. Nugent R. Bringing Agriculture to the Table: How Agriculture and Food Can Play a Role in Preventing Chronic Disease. The Chicago Council on Global Affairs. 2011. Accessed October 11, 2015. http://www.thechicagocouncil. org/publication/bringing-agriculture-table-how-agriculture-and-food-policycan-play-role-preventing.
393. Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, Engell RE, Lim S, Danaei G, Mozaffarian D, On behalf of the Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE). Global, regional, and national sodium intakes in 1990 and 2010: a systematic analysis of 24-hour urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3:e003733.
394. Micha R, Khatibzadeh S, Shi P, Andrews KG, Engell RE, Mozaffarian D. Global, regional and national consumption of major food groups in 1990 and 2010: a systematic analysis incluDing 266 country-specific nutrition surveys worldwide. BMJ open. 2015;5:e008705
395. Singh GM, Micha R, Khatibzadeh S, Shi P, Lim S, Andrews KG, Engell RE, Ezzati M, Mozaffarian D; Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE). Global, regional, and national consumption of sugar-sweetened beverages, fruit juices, and milk: a systematic assessment of beverage intake in 187 countries. PLoS One. 2015;10:e0124845. doi: 10.1371/journal.pone.0124845.
396. Deckersbach T, Das SK, Urban LE, Salinardi T, Batra P, Rodman AM, Arulpragasam AR, Dougherty DD, Roberts SB. Pilot randomized trial demonstrating reversal of obesity-related abnormalities in reward system responsivity to food cues with a behavioral intervention. Nutr Diabetes. 2014;4:e129. doi: 10.1038/nutd.2014.26.
397. Mozaffarian D. Salt, sugar, and fat or branding, marketing, and promotion? The Lancet. 2013;382:1322-1323.
398. Mozaffarian D, Wilson PW, Kannel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation. 2008;117:3031-3038. doi: 10.1161/CIRCULATIONAHA.107.738732.
399. Bodenheimer T. Helping patients improve their health-related behaviors: what system changes do we need? Dis Manag. 2005;8:319-330. doi: 10.1089/dis.2005.8.319.
400. Simpson LA, Cooper J. Paying for obesity: a changing landscape. Pediatrics. 2009;123(suppl 5):S301-S307. doi: 10.1542/peds.2008-2780I.
401. Long MW, Tobias DK, Cradock AL, Batchelder H, Gortmaker SL. Systematic review and meta-analysis of the impact of restaurant menu calorie labeling. Am J Public Health. 2015;105:e11-e24. doi: 10.2105/AJPH.2015.302570.
402. Shangguan S, Smith J, Ma W, Tanz L, Afshin A, Mozaffarian D. Effectiveness of point-of-purchase labeling on dietary behaviors and nutrient contents of foods: A systemic review and meta-analysis (abstract). Circulation. 2015;131:AP323-AP323.
403. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356:2388-2398. doi: 10.1056/NEJMsa053935.
404. Institute of Medicine. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. Washington, DC.: The National Academies Press; 2010.
405. Nestle M. Food Politics: How the Food Industry Influences Nutrition, and Health, Revised and Expanded Edition. Los Angeles, CA: University of California Press; 2007.
406. Centers for Disease Control and Prevention (CDC). Motor-vehicle safety: a 20th century public health achievement. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4818a1.htm. Accessed December 17, 2015.